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ABSTRACT 
Recent outbreaks and recalls linked to Listeria monocytogenes and shiga toxin-producing 
Escherichia coli in soft-ripened raw milk cheese illustrates an urgent need to identify effective 
controls compliant with Standards of Identity of cheese. The Food Safety Modernization Act 
(FSMA) presents an additionally hurdle by requires producers develop and implement science-based 
preventive controls for biological hazards associated with their product as part of a formal food 
safety plan, however few strategies have been formally documented in the scientific literature. 
Protective cultures of lactic acid bacteria (PCs) represent one such actionable and compliant 
solution, yet laboratory strains which have been documented effective are not available for 
widespread use. A selection of cultures is commercially available and safe for use in food but 
their compatibility with common cheese flora and antimicrobial efficacy against pathogens in the 
presence of raw milk consortia and in raw milk cheese production is unknown. Here, using 
culture based methods ten protective cultures were tested for inhibition of common 
cheesemaking starter cultures, ripening bacteria, yeasts and molds. Nine were confirmed 
compatible with starter cultures. PC inhibition of ripening bacteria and fungi was strain specific. 
Nine of the protective cultures did not inhibit acid production of the starter cultures tested. A 
subset of five cultures of these cultures was then tested for activity against L. monocytogenes by 
co-inoculating cultures into raw milk with the pathogen (7:2 log CFU/mL) and then experiencing 
a temperature profile similar to that of cheesemaking. Two cultures did not impact growth of L. 
monocytogenes, two cultures exerted a bacteriostatic effect and one culture limited L. 
monocytogenes to <1 log CFU/mL throughout testing. Similar testing completed using STEC 
similarly identified a separate efficacious culture towards that pathogen. Soft-surface mold 
ripened cheese was then manufactured using raw milk inoculated with the respective pathogens 
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and challenged with these efficacious cultures. Treatment with Protective Culture did not reduce 
L. monocytogenes counts in milk over ripening. L. monocytogenes grew in cheese treated with 
nisin-producing protective culture. STEC survived in soft-ripened cheese for over 120 days of 
ripening, however the addition of Protective Culture did not impact rate of survival. These results 
identify the select compatibility of protective cultures with cheesemaking cultures and the 
potential for select PCs to control L. monocytogenes in raw milk.  However further work is 
needed to optimize application and use parameters for sustained control of pathogens in soft 
surface mold-ripened cheese.  
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CHAPTER I 
INTRODUCTION 
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Centers for Disease Control researchers estimate that consumption of unpasteurized dairy 
products is 150 times more likely to result in food borne illness than pasteurized dairy (6). 
Among the pathogens associated with raw dairy, Listeria monocytogenes and shiga-toxin 
producing Escherichia coli (STEC) each present significant public health risk.  Listeriosis is a 
serious infection caused by L. monocytogenes and associated with high rate of hospitalization 
and mortality (11). Infection with STEC requires a low infectious dose and has the chance to 
develop into a type of kidney failure known as hemolytic uremic syndrome (HUS) which 
requires hospitalization (8). Both pathogens have been isolated from the farm environment (1, 7), 
raw milk (14), and raw milk cheeses (2, 12). A multistate outbreak of listeriosis in 2017 was 
linked to a raw milk cheese produced in New York and caused 8 hospitalizations and two deaths. 
This year, 2019,  in France soft cheeses made from unpasteurized milk by one manufacturer 
initiated a multi-country recall after being linked to outbreak of 16 STEC infections of which 14 
children all less than four years old developed HUS  (4, 5).  
Soft-ripened cheese presents a unique food safety hazard because physiochemical 
changes, notably pH,  in the product occur over ripening and mandatory aging allows for growth 
of L. monocytogenes (10). US Food and Drug Administration (FDA) and Health Canada 
conducted a joint quantitative risk assessment of L. monocytogenes in soft-ripened raw milk 
cheese in 2014. The report identified the heightened risk of listeriosis after the mandated 60 day 
aging period but failed to identify potential solutions to manage this risk beyond pasteurization 
(13). The report confirms a 50- to 160- fold increase in listeriosis risk from cheese made from 
raw milk compared to pasteurized milk in Canada and the United States respectively. 
The use of protective cultures (PCs) of lactic acid bacteria (LAB) as a biological control 
strategy in fermented dairy is promising as it has already been demonstrated an effective strategy 
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for control of L. monocytogenes in other food applications (3). Application of PCs in cheese is 
advantageous as it is compliant with standards of identity of cheese, follows clean-label desires 
of consumers, and maintains Generally Regarded as Safe status for use in food by the FDA. 
Protective cultures exert antimicrobial activity on unwanted spoilage and pathogenic organisms 
through the production of one or antimicrobial metabolites, chiefly organic acids, hydrogen 
peroxide, and antimicrobial peptides known as bacteriocins (9). Activity of these metabolites, 
except for bacteriocins, is non-specific. Bacteriocin activity, in contrast, is frequently limited to 
bacteria taxonomically similar to the producer. LAB are Gram-positive and exert stronger 
antimicrobial activity towards similar Gram-positive organisms, notably pathogen L. 
monocytogenes. The impact of the same Gram-positive cultures, especially those commercially 
available, on Gram-negative STEC is limited. Gram-negative cultures have been also found to 
exhibit similar antimicrobial potential within other Gram-negative bacteria, however research is 
far less abundant than that of LAB. In consequence, number commercial protective cultures 
active against Gram-negative bacteria is also limited.    
Successful reports of PC use in cheese in scientific literature employ cultures not 
available to producers. Further, these studies are frequently conducted in pasteurized milk, so 
efficacy in the presence of mixed microflora of raw milk is unknown. Commercially available 
PCs exist but their antimicrobial efficacy, especially in in raw milk, has not been verified. 
Additionally, non-specific nature of antimicrobial activity suggests that use of PCs as an adjunct 
culture has the potential to impact activity of desired cheese flora- starter cultures, ripening 
bacteria, yeasts, and molds. Use of PCs in cheese production would be easy to implement and a 
low-cost option for cheesemakers. 
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The hypothesis guiding this work is that PCs exert inhibitory and bactericidal effects against 
L. monocytogenes and STEC without significantly affecting beneficial cheese microbiota and their 
activity. The specific objectives of this research are as follows: 
1. Identify compatible combinations of commercial protective and cheesemaking cultures.  
2. Determine the antimicrobial activity of commercial protective cultures against L. 
monocytogenes.  
3. Determine the effect of commercial protective cultures on L. monocytogenes and STEC 
during the manufacture and storage of soft-ripened cheese manufactured from raw milk.  
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CHAPTER II  
REVIEW OF THE LITERATURE 
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1. MILK FOR CHEESEMAKING 
In the United States cheese is defined according to the Code of Federal Regulations 
(CFR) which reads as follows: “the fresh or matured product obtained by draining after 
coagulation of milk, cream, skimmed, or partly skimmed milk, or a combination of some or all of 
these products, and including any cheese that conforms to the requirements of the Food and Drug 
Administration (FDA) for cheeses and related cheese products” (14). American author Clifton 
Fadiman went as far to say cheese was “Milk’s leap to immortality” (69). Cheesemaking has 
been a time honored way to preserve milk to last long after its normal fluid shelf life. 
Milk which has not undergone pasteurization, a specific heat treatment to reduce bacterial 
load in the milk, is considered raw (95). Raw milk, therefore, may contain a combination of 
bacteria that serve a functional purpose in cheesemaking and those that pose a hazard to human 
health. Fluid raw milk is not federally legal for sale (95). Cheesemaking with raw milk remains 
the only exception to this law. The legalization status of fluid raw milk remains a point of 
contention among public health officials, consumers, and producers because of the hazard to 
health. Debates regarding raw fluid milk are markedly different than those for raw milk cheese 
and will not be addressed here. To protect public health and manage potential health risks, 
several federal regulations present a framework of safety through which raw milk cheeses can be 
made. 
1.1 Motivations for Use of Raw Milk for Cheese 
The traditional, historic use of raw milk and the diversity of endogenous microbes in raw 
milk contribute flavor and texture of cheese are the two primary reasons cheesemakers select raw 
milk for their cheese. Bacteria enter the milk directly from the lactating animal (Cow, goat, 
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sheep, buffalo etc.) at the time of production, from the milking method, and from the milking 
environment (72). For example, Lactococcus species, commonly found in raw milk and 
responsible for acid development from fermentation, are frequently found on the cow’s teat (65). 
Hygienic practices during milking- specifically teat dipping- has been found to reduce the level 
of lactic species in the milk, which may be a detriment to cheesemakers (58, 100). Commercial 
starter cultures are comprised of select species of this genera and are used to repopulate milk 
after pasteurization to precisely restore the activity (84). Before the advent of pasteurization and 
modern cheesemaking cultures all cheeses were made from raw milk and employed the natural 
microflora for fermentation. The diverse microbial population contributes a complement of 
enzymatic activity, enhancing the diversity of flavor compounds produced (3). Studies 
comparing cheeses made from raw and pasteurized milk find differences in flavor with mixed 
outcomes on desirability. For example, researchers comparing cheddar cheese made from raw, 
pasteurized, or microfiltered skim milk observed detrimental flavor differences in cheddar made 
from raw milk compared to pasteurized (61). Beuvier et al. (1997) found that Swiss cheese made 
from raw milk had higher scores for overall aroma intensity, pungency, firmness and granular 
character compared to pasteurized (6). Potential for one-of-a-kind flavor is a marketing point for 
raw milk cheeses (20).  
The rich history of cheese production in Europe, is honored through the continuation of 
historic methods (by hand, smaller volumes), mechanisms (wooden aging shelves, ripening 
barrels), and material (raw milk). Specific cheeses are protected by law through Protected 
Designation of Origin (PDO) or similar national programs. PDO designations ensure the 
integrity of the cheese, confirming it is from the intended geographic area and follows standards 
of production, care, and quality. This is both a marketing tactic and boon to particular local 
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economy. Variation in microbiology across a geographic region can manifest in a terroir, or 
specific taste for that region (41). Well known cheeses with geographical protected designations 
include Camembert and Parmigiano-Reggiano. Presently, there is no PDO equivalent in the 
United States for cheeses; however cheesemakers adopt practices- such as the use of raw milk- 
with the intent of producing cheese unique to their region (53). 
Sources of bacteria in the environment and animal, such as those described earlier, 
contributing to the microbial population in raw milk are many. The same sources may also 
harbor and contribute pathogenic organisms such as Salmonella ssp, Campylobacter jejuni, 
Listeria monocytogenes, and shiga-toxin producing Escherichia coli (72). All of these organisms 
cause serious infection in humans. Vigilant hygiene at all steps of milk production- from 
husbandry, collection, storage and transport- contributes greatly to microbial quality and safety 
of the milk. However the best way to eliminate pathogens and manage the risk to public health is 
pasteurization.  
1.2 Pasteurization and Pasteurized Milk Ordinance (PMO) 
Introduction of pasteurization reduced the incidence of milk borne disease from ~25% of 
all foodborne disease outbreaks in 1938 to <1% today (95). Pasteurization is the heating and 
holding of every particle of milk at a prescribed temperature for a set time, typically 161°F for 15 
seconds (95). Approved time-temperature variations, such as High temperature- Short Time and 
Low Temperature-Long time, are specified in the Pasteurized Milk Ordinance (PMO) document. 
Stringent adherence to all PMO directives by operators is the cornerstone to a safe milk supply. 
In addition to the public health benefit, removal of bacteria via pasteurization offers quality 
advantages. Without batch to batch variation in microbes, consistent cheese is more reliably 
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made with pasteurized milk. Such removal stands in direct contrast with the philosophy of raw 
milk cheese makers who rely on and employ these bacteria for their make.  
1.3 Standards of Identity 
In the United States, Standards of Identity (SOI) are a legal definition of a product 
outlining the ingredients, composition and key methods of manufacture (14). Not all cheeses 
have a standard of identity. Unlike PDO mentioned previously, SOI are chemically, not 
geographically based. If a product is to be legally labeled as a standard cheese type, ingredients 
allowable in a cheese product are limited to those listed in the SOI. SOI further define if raw 
milk is allowed in each specific cheese type. Use of raw milk in cheese is not universal and in 
non-designated cheeses would be illegal. 
1.4 60-Day Rule 
Public health concern regarding consumption of raw milk and raw milk products stems 
from the potential for contamination of the product with pathogenic microorganisms. Among 
these are Listeria monocytogenes, shiga-toxin producing Escherichia coli, Salmonella species, 
Campylobacter jejuni, Brucella species, and Mycobacterium tuberculosis (13). Observations that 
younger aged raw milk cheeses were more frequently implicated in outbreaks than older cheeses 
made from raw milk, lead to state and eventual federal adoption of regulations requiring 
prolonged aging of raw milk cheeses (39, 79). Text in the federal SOI allowing use of raw milk 
states that the cheese made from raw milk must be aged for at least 60 days at a temperature 
greater than 1.6 ºC (35 ºF). Documented pathogen survival in cheeses of multiple types past the 
60 aging period indicates that extensive aging is not a complete guarantee of safety (23). 
 
 
12 
 
1.5 Food Safety Modernization Act (FSMA) 
The most recent piece of food safety legislation, the Food Safety Modernization Act, 
responds to the changing hazards in our food landscape including a more globalized food system 
and growing population of consumers susceptible to illness. Cheesemakers are required to 
prepare a food safety plan that 1) identifies hazards associated with their product, 2) installs 
appropriate, science-based preventive controls to manage each hazard, and 3) justifies and 
documents that such preventive controls adequately manage the risk identified.   
2. LISTERIA MONOCYTOGENES 
2.1 Microbiology 
Listeria monocytogenes is a Gram positive non spore-forming rod in the genus Listeria 
(31). The Listeria genus contains seven species including Listeria ivanovii which infects animals, 
however Listeria monocytogenes is the only species to infect humans (31). Within L. 
monocytogenes there are 13 serotypes, of which 1/2a 1/2b, and 4b cause 95% of infections (11).  
L. monocytogenes is labile to pasteurization and is capable of growing at refrigeration 
temperatures (31). L. monocytogenes may enter raw milk from multiple sources. On the farm, 
udders with mastitis from L. monocytogenes infection can shed the bacteria directly into the milk 
(87). Poor hygienic practices during milk collection can also transfer L. monocytogenes shed in 
feces into milk (52). In cheesemaking facilities L. monocytogenes is commonly isolated from 
cool and damp niches such as seams in equipment and floor drains (52). L. monocytogenes can 
persist in these areas and on improperly cleaned and sanitized equipment by forming biofilms, 
leading to post-pasteurization contamination of products (2, 32). For example, L. monocytogenes 
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was found on floors, in floor drains, and plastic crates used for multiple tasks across a Latin-style 
cheese facility (49).   
2.2 Pathogenicity  
An infection with the bacteria is known as listeriosis. Ingestion of food contaminated 
with the organism is the most likely route of exposure. In immune-competent individuals 
infection is characterized by mild symptoms of general food borne illness, but is rarely 
encountered and even more rarely diagnosed because of the large infectious dose required (10). 
In vulnerable populations including the pregnant, elderly, very young and immune compromised; 
infections can spread beyond the GI tract reaching the bloodstream as sepsis or the brain as 
meningoencephalitis. In pregnant women, listeriosis infection can cause stillbirth (21, 31). As 
such, infection in any of these populations results in higher rates of hospitalization (94%) and 
death (15.9%) than other food borne infections (86). Further, listeriosis symptoms are reported 
anywhere from 7 to 70 days after exposure, making trace back to implicated food difficult (10). 
The precise infectious dose and risk of illness modulates based on immune status, volume 
consumed and cell concentration. For example, Pouillot et al. (2016) estimated contamination 
levels of ice cream associated with multi-state outbreak of listeriosis ranged from 0.12 to 8 
CFU/g of product (71).  Serving sizes of each product varied but researchers estimate the general 
population ingested anywhere from 1.5  109 to 1.4  1010 cells, but vulnerable populations 
ingested 7.2  106 to 3.3  107 (71).  
2.3 L. monocytogenes Prevalence in Bulk Tank Milk and Cheese 
 Detection of L. monocytogenes in bulk tank raw milk highlights the continued public 
health risk associated with cheese products made from raw milk. Van Kissel et al (2011) found 
Listeria ssp. isolates in 43 out of 536 bulk tank milk samples (7.1% weighted) , 24 of which were 
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later confirmed to be L. monocytogenes taken from the 2007 National Animal Health Monitoring 
System (NAHMS) Dairy Survey (98). This data set included both large and small farms. This is 
a slight increase from detection of Listeria ssp. in 6.5% of samples five years prior (99). Of bulk 
tank milk samples collected from 248 dairy herds in Pennsylvania from 2001-2002, only 3 
samples returned positive for L. monocytogenes (45). In a survey of milk used for small-scale 
artisan cheesemaking in Vermont, Listeria spp. was detected by PCR in only 1 sample of the 101 
tested (24). This isolate was confirmed to be L. innocua, PCR confirmation for L. monocytogenes 
for this sample was negative. Low prevalence of L. monocytogenes in bulk tank milk illustrates a 
viable, but low risk of pathogenic L. monocytogenes for raw milk cheese maker. Potential for 
environmental contamination mentioned previously further compounds risk for product 
contamination with L. monocytogenes.  
 Prevalence of L. monocytogenes in cheeses in US commerce is low. Recent sampling 
assignment of raw milk cheeses in the US conducted by the FDA in 2014 found ten of 1,606 
samples tested positive for L. monocytogenes (96). Nine out of ten of these positive samples 
were semi-soft raw milk cheeses. The total contamination rate of this cheese type by L. 
monocytogenes was 0.89%.  
Despite low prevalence, outbreaks of listeriosis attributed to unpasteurized cheese do 
occur. Gould et al. (2014) reports that of outbreaks of food borne illness associated with cheese 
occurring from 1998-2011, L. monocytogenes was more often associated with pasteurized cheese 
(8 out of 44 outbreaks), than unpasteurized (4 out of 38 outbreaks) (40). Soft cheese was most 
frequently implicated in these outbreaks. Sixty- two percent of the cheeses made from 
unpasteurized milk were contaminated by animals or the environment, whereas poor worker 
hygiene and bare hand contact were contributing factors more frequently associated with 
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outbreaks associated with pasteurized cheese (40).  Jackson et al. (2018) and Costard et al. 
(2017) noted a similar association of pasteurization status and cheese type when analyzing 
outbreaks of listeriosis from 1998 to 2014 (22, 44). In 2017 a raw milk cheese produced in New 
York caused a multi-state outbreak of Listeriosis linked which resulted in eight hospitalizations 
and two deaths (12). An outbreak of listeriosis in France in early 2019 attributed to 
“l’Explorateur soft ripened cheese” made from raw milk caused two deaths and prompted 
international recall (35). Since the beginning of 2017, the FDA has issued 21 recalls related to 
potential or confirmed contamination of cheese products with L. monocytogenes (36). 
3 SHIGA TOXIN-PRODUCING ESCHERICHIA COLI (STEC) 
3.1 Microbiology 
 Escherichia coli is a diverse species of bacteria common to the intestines of humans and 
animals, the environment and foods. STEC are Gram-negative bacilli, mesophilic, and aerobic. 
Most strains of Escherichia coli do not cause disease. Of relevance to the food industry are 
strains that cause gastrointestinal illness on a continuum of severity known collectively as 
diarrheagenic E.coli. These pathogenic strains are grouped by manifestation of illness. These are, 
enterohemorrhagic/Shiga Toxin Escherichia coli (EHEC/STEC) (also called verocytoxic 
Escherichia coli VTEC), enterotoxigenic Escherichia coli (ETEC), enteropathogenic 
Escherichia coli (EPEC), enteroaggregative Escherichia coli (EAEC), enteroinvasive 
Escherichia coli (EIEC), and diffusely adherent Escherichia coli (DAEC). Escherichia coli 
strains are further distinguished from one another based on surface antigens O (somatic), H 
(flagellar) and K (capsule), A specific O and H combination or lack thereof defines a serotype 
(67). Of particular concern to the food industry and the focus of this work are the shiga-toxin 
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producing Escherichia coli (STEC). EHEC are a distinct subgroup of STEC distinguishable by 
more severe clinical illness characterized by hemorrhagic colitis and hemolytic-uremic syndrome 
(HUS). Both STEC and EHEC are characterized by the production of one or both shiga-like 
toxins Stx1 and Stx2 (68), however EHEC strains produce additional virulence factors associated 
with more severe symptoms including the cell surface protein intimin, and enterohemolysin (27). 
The combination of proteins allows the bacteria to attach to intestinal cells and excrete toxin, 
causing more severe symptoms of infection. Historically in the United States EHEC infections 
have been associated with the serotype O157:H7, however detection of non-O157:H7 serotypes 
in patients with HUS have prompted the public health community to refer to EHEC infections by 
their serotype.  
3.2 Pathogenicity 
 Symptoms of STEC infection include severe abdominal pain diarrhea that may be 
bloody, occasionally a low grade fever, lasting up to 5-7 days (9). The CDC reports that 5-10% 
of STEC infections develop into a life-threatening acute renal failure known as hemolytic uremic 
syndrome (HUS) (9, 68). As mentioned previously, HUS is historically associated Escherichia 
coli serotype O157:H7, and this serotype remains the most frequent Escherichia coli serotype 
implicated in food borne infections resulting in HUS. Non-O157:H7 serotypes O26, O111,O103, 
O121, O45, O145 have been implicated in outbreaks and cases of HUS (7).The infectious dose 
for STEC is often reported as <100 cells, regardless of serotype (9, 47, 68). STEC can infect 
individuals at any age, however, children  younger than 5 have the highest incidence of HUS (9). 
Hospitalization rate estimations for STEC are further subdivided to O157 and non-O157 with 
rates at 46% and 12.8%  respectively (86). Death rates for O157 and non O157 STEC are 0.5% 
and 0.3%, respectively, however patients surviving HUS will require lifelong medical care (86). 
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An outbreak of STEC infections in spring of 2019 linked to a raw milk surface mold-ripened 
cheese had 15 pediatric cases (< 4 years old) and 14 of which developed HUS (48). 
3.3 Prevalence of STEC in Bulk Tank Milk 
STEC has been periodically detected in raw bulk tank milk. Jayarao et al. (2006) reported 
six isolates out of 248 samples of STEC in bulk tank raw milk in Pennsylvania (45) and 5 out of 
131 isolates from South Dakota and Minnesota (46). Van Kissel et al. (2011) detected shiga 
toxin genes using real time PCR in 78 of 533 bulk tank milk samples, after weighting, this is 
2.3% of operations surveyed (98). In all of these surveys, STEC was not the most frequently 
isolated pathogen, indicating that multiple pathogens contribute to the high risk of the product. 
Monitoring for STEC in raw milk used for cheesemaking is not required by law, however 
periodic confirmation of absence in raw milk used for cheesemaking is a recommended practice 
(1).  
3.4 Prevalence and Detection of STEC in Cheese 
Detection of the stx gene via PCR is the approved method for confirming presence of 
STEC. This method is more reliable than agar based approaches because of sensitivity and time 
to results. Madic et al. (2011) screened 400 raw milk soft or smear semi-hard cheeses available 
for retail sale in France for STEC serotypes using real time PCR (56). 29.8% of samples were 
positive for stx, 55.3% contained at least one of the five EHEC O group markers (O157, O145, 
O103, O26, O111), and 37.3% contained the eae gene; 61 samples contained all three. Fifteen 
isolates were obtained from a subset of samples showing EHEC associations of markers. Authors 
reported prevalence of stx-positive cheese was mixed in comparison to others studies. In a 
separate study 136 out of 1039 French raw milk cheese samples, 74 of which were soft cheese, 
tested positive for stx (101). Vernozy-Rozand et al. (2005) recovered 32 strains of STEC from 18 
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samples of cheese, however none of these isolated contained the combination of three genes 
(stx1, stx2, and eae) associated with serious infection (101). These studies show that virulence 
genes stx are readily detected in raw milk cheeses of Europe, however, multiple virulence factors 
are necessary for associated infection. 
4 SURFACE-MOLD RIPENED SOFT CHEESE 
4.1 Cheese Make 
 Surface mold ripened soft cheeses include Brie, Camembert and their variants such as 
Chaource and coulommiers. Also called bloomy rind cheeses, this group is characterized by the 
fluffy white mold of Pennicillum candidum and Geotricum candidum on the surface. A 
traditional cheese of French villages, surface mold cheeses are manufactured by ripening the 
milk with either added starter culture or allowing endogenous Lactic Acid Bacteria to acidify the 
milk, renneting, and limited cutting and cooking of the curd before ladling into forms. As the 
story goes, prior to industrialization of cheese cultures, Penicillium molds colonized the cheese 
from the air during the time local women making cheese would attend to other household chores 
in between making cheese (50). In the United States a standard of identity exists only for soft-
ripened cheese category, rather than specific cheeses. 21 CFR §133.182 specifies soft-ripened 
cheeses shall have 50% fat in dry matter and use of raw milk is allowed with required aging time 
(14).  
4.2 Physiochemical and Microbial Community Changes  
Presence and growth of the surface microbial community is a critical component for the 
ripening of the cheese. Leclercq-Perlat et al. (2004) manufactured pasteurized camembert to 
observe microflora and biochemical changes of the surface during ripening (54). Growth of the 
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yeast Kluyveromyces lactis occurred rapidly on the cheese surface in the first two days, and 
slowed in rate until day 7, at which point cell concentrations remained constant out to day 45. 
Growth of Geotrichum candidum at the surface occurred mainly between day 3 and day 12, after 
which time cell concentrations remained constant. Growth of P. candidum was observed between 
day 7 and 12, with uniform coverage achieved by day 12-14. Brevibacterium linens, grew on the 
surface exponentially starting at day 5 until day 8. pH of the surface of the cheese started at 4.7; 
at day 6 it began to increase rapidly to 7.7 on day 9. pH of the core increased gradually starting at 
day 13 to a pH of 7.0 on the last day of ripening. Complete depletion of lactose occurred from 
day 2 to day 8, accompanied by an increase in lactate concentration peaking at day 6 and 
decreasing gradually throughout the remainder of ripening. Aligning the microbial growth 
timelines with those of the biochemical changes describes the dynamic changes occurring on and 
in the cheese. Growth of K. lactis correlates with the depletion of lactose on the rind.  Lactose is 
not a substrate for G. candidum growth, therefore growth of G. candidum is not observed until its 
substrate lactate is present in sufficient amounts. Growth of G. candidum instigates the increase 
in pH at the rind through the production of proteases, which upon cleaving proteins release 
ammonia raising the pH. The rise in pH gives B. linens and P. candidum an opportunity for 
growth. The cascade of community development is therefore closely tied to biochemical changes 
occurring in the chees as a result of other members; however these changes also support 
pathogen survival.   
4.3 Pathogen Survival and Growth in Soft-Ripened Cheese  
Changes in composition through ripening support growth of Listeria monocytogenes and 
survival of STEC in surface mold ripened cheese. In a seminal study of L. monocytogenes in 
camembert cheese, Ryser and Marth (1987) manufactured pasteurized camembert with 2 log 
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CFU/mL L. monocytogenes in the milk, and monitored pathogen counts and pH throughout the 
cheese make and ripening (80). Ripening and pH changes at surface and interior of these cheeses 
closely followed that described previously. Fate of Listeria was strain specific with strains Scott 
A, CA and OH experiencing brief 1-2 log reduction in the first two weeks while the pH of the 
cheese was still low. Then as pH at the surface increased, growth to 8 log CFU/g occurred. 
Absence of early reduction in counts was the only point of difference in the growth of strain V7 
from the other strains in this cheese. Montet et al. (2009) observed a slight increase (<2 log 
CFU/g) in concentration of cocktails of four acid resistant and non-acid-resistant strains of 
STEC, throughout manufacture and drying (66). Counts of one non-acid resistant strain 
decreased to 1 log CFU/g by the end of the 20 days of ripening while the remaining strains 
showed either slight growth to 4 log CFU/g or mild decrease to 2 log CFU/g from the initial 
inoculation of 3 log CFU/mL (66). Strain specific survival patterns of STEC O157:H7, O26:H11, 
O103:H2, and O145:H28 were observed in a lactic cheese made by Miszczycha et al. (2013). 
Serotype O26:H11 was the only strain to increase in concentration throughout manufacture. At 
the end of de-hooping, all strains were below the limits of enumeration, but were detectable after 
enrichment (63). In a follow-up study by Miszczycha et al. (2016) STEC strains O26:H11, 
O103:H2, O145:H28, and O157:H7 also varied in rate of survival in soft-ripened cheese, 
indicating the pathogen survival in this cheese type is strain specific.  
4.4 FDA/Health Canada Risk Assessment 
Association of soft-ripened cheese with sporadic and outbreak related listeriosis 
infections prompted the FDA and Health Canada to assess the risk posed by this product and 
identify potential interventions (97). Using a mathematical model based on rates of consumption 
in the population, health status of the populations and rates of contamination, among other 
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variables, assessors calculated a 50- to 160- fold increase in the risk of listeriosis form 
consumption of soft-ripened cheese made from raw milk compared to pasteurized milk in 
Canada and the United States, respectively. The assessment identified that periodic sampling of 
individual lots of raw milk cheese would not reduce the risk to below that of pasteurized milk, 
however sampling every lot and removing positive lots would sufficiently reduce the risk. 
Further, applying a treatment which reduces L. monocytogenes population by 6 log CFU/mL 
would also reduce the risk of illness, however no such intervention has been identified. Removal 
of the required ripening period of 60 days reduced risk of illness to 62 times that of the 
pasteurized baseline. Models of an antimicrobial treatment reducing 2 log CFU/g on the surface 
of the cheese only reduced the rate of listeriosis to 37 times higher than that of pasteurized milk 
cheese. This model did not investigate reduction of L. monocytogenes in the interior of the 
cheese. 
 
5. PROTECTIVE CULTURES 
5.1 Overview of Protective Cultures 
Lactic acid bacteria (LAB) serve a multiple roles in successful food fermentations 
namely, converting substrates to generate desired flavors and textures, and producing of 
metabolites with antimicrobial properties to extend acceptable shelf-life of the product. 
Antimicrobial properties of protective cultures stem from production of one or more metabolites 
chiefly organic acids, but also includes hydrogen peroxide, ethanol, selective enzymes, and of 
particular interest, bacteriocins (15). Protective cultures have been evaluated for applications in 
multiple food industries (meat, seafood, produce) and are particularly well suited for fermented 
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dairy products because of rich growth medium, documented safety, and successful control of 
pathogens in these products (89). 
Bacteriocins are ribosomally produced peptides with antimicrobial potential. 
Classification of these compounds is determined by producing organism and structure. 
Bacteriocins of Gram positive bacteria fall into three classes. Class I bacteriocins are known as 
lanthionine-containing lantibiotics and include nisin A and Z. Class II bacteriocins do not contain 
lanthionine and are further subdivided into 3 subclasses. Class III bacteriocins are larger and 
unstable to heat. Bacteriocins of Gram negative bacteria are classified according to similarity to 
the major bacteriocins colicin or microcin. Bacteriocins are most active against competitors 
similar to the producing strain. Bacteriocins of Gram positive bacteria inhibit competitors 
through preventing membrane synthesis and forming pores in the membrane (64, 105). 
Bacteriocins of Gram negative bacteria exert antimicrobial activity through pore formation, 
inhibition or digestion of genetic material, or digestion of peptidoglycan precursors (105). 
5.2 Control of Pathogens with LAB 
Multiple studies have demonstrated antipathogenic activity of LAB strains. Spelhaug et 
al. (1989) observed inhibition of food borne pathogens Bacillus cereus, Clostridium perfringes, 
Staphylococcus aureus, select species of the Listeria genus, and slight inhibition of strains 
Escherichia coli O157:H7, Vibrio cholera 851, V. parahemolyticus A865957 by Lactococcus 
lactis subsp. lactis 11454, Pediococcus pentosaceous FBB61, and P. pentosaceous FBB63-DG2, 
but did not observe inhibition of Campylobacter jejuni, Salmonella enteriditis, Yersina or Vibrio 
species (93). This analysis was completed using agar based assays, giving a broad approximation 
of antimicrobial potential. This study confirmed strain-specific and narrow spectrum of 
inhibitory activity of LAB. Similarly, Harris et al. (1989) while testing a panel of 14 LAB strains 
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identified three cultures that produced proteinaceous compounds that inhibited L. 
monocytogenes.  Many studies similar to these are available in the literature with variations in 
culture origin and intended antimicrobial activity. A limited number of the cultures examined 
have demonstrated anti-pathogenic activity in dairy, and even fewer have been manufactured for 
commercial use in dairy applications.  
5.3 Commercially Available Protective Cultures 
Available information pertaining to the commercialized strains of protective cultures 
selected for use in the experiments that follow is summarized here. In the absence of published 
literature using the specific culture, studies using anther strain of the same species is presented to 
illustrate potential for antimicrobial activity.  Lack of available and non-codified scientific 
literature to document validation of process controls is one hurdle processors encounter when 
drafting a food safety plan. 
5.3.1 Pediococcus acidilactici B-LC-20 
B-LC-20 is a culture of Pediococcus acidilactici manufactured by Chr. Hansen 
(Denmark) for the control of Listeria monocytogenes in fermented sausage products (18). 
Technical document supplied by the manufacturer indicates the culture can be used as an adjunct 
to normal sausage making, not a surface application (18). This Pediococcus strain has an optimal 
growth temperature at 43°C and does not ferment lactose. Patent application for the product 
further specifies the strain as Pediococcus acidilactici strain DSM 10313 (94). 
In an evaluation completed by Raimondi et al. (2014) of a Lactobacillus delbrueckii strain for 
potential bio-protective properties, B-LC-20 was used as a benchmarking control for anti-listerial 
activity (73). Acidification of meat blend was not impacted by the addition of B-LC-20, the final 
pH of the mixture after incubation at simulated fermentation temperatures was not statistically 
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different from controls, however the rate of acidification was higher than control. L. 
monocytogenes was inoculated into the meat at 5103CFU/g and challenged with 5106CFU/g of 
the protective culture. At start of fermentation, L. monocytogenes numbered ~1104CFU/g, and 
from day 3 onward counts of L. monocytogenes in sausages fermented with B-LC-20 were lower 
than control. At the end of 21 days of fermentation, L. monocytogenes counts had decreased by 
1.21 log CFU/g, whereas in the same timeframe the control decreased by 0.34 log CFU/g, 
evidence of the potential for this culture to manage L. monocytogenes growth and proliferation in 
this product. Patent materials also report an average reductions in Listeria monocytogenes 
cocktail in a sausage at 2.71 and 3.06 log CFU/g for low (~2.9 107CFU) and high (~5.6 
107CFU) concentrations of B-LC-20 respectively (94). The application also describes the 
product produces a class II bacteriocin. Other Pediococcus species commonly produce the 
bacteriocin pediocin, a class II bacteriocin capable of forming pores in target cell membranes 
(33, 75). Minimal acid development and reported high activity against L. monocytogenes in a 
high-acid fermentation environment prompt investigation of cross-application of this culture for 
similar use in cheese. 
5.3.2 Lactobacillus curvatus B-LC-48 
B-LC-48 is a frozen pelletized culture of a strain of Lactobacillus curvatus, manufactured 
by Chr. Hansen (Denmark) and marketed with the expressed purpose of ‘minimizing the 
presence of Listeria monocytogenes in cooked, sliced bacon’ according to the manufacturer’s 
website (19). This culture is speculated to produce the bacteriocin curvatin. Technical 
documentation for the product also claims the product can be used in “Ready-to-Eat foods which 
are packed under vacuum or modified atmosphere and cold stored…particularly meat products” 
(19). This culture does not ferment lactose. 
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Previous investigations using this culture have reported reductions of Listeria monocytogenes in 
meat applications; however a report of use in cheese exists. Rodriguez et al. (2012) evaluated B-
LC-48 to control Listeria and E.coli O157:H7 in fresh micro cheeses over 21 days of storage, 
reporting 6 log CFU/g reduction of E.coli O157:H7 ATCC 43888 and 2 log CFU/g reduction of 
L. monocytogenes (77). This study is one of the few reported uses of this culture in cheese. In his 
thesis Frank Dogbatsey investigated the use of protective cultures B-LC-48 and B-LC-20 
singularly and in combination as starter cultures in genoa salami production and for the control 
of L. monocytogenes in the same product (29). Application of each PC alone reduced L. 
monocytogenes populations by day seven. However, when combined reduction accelerated and 
was observed earlier on day 4 (29).  
5.3.3 Lactobacillus plantarum HOLDBAC 
Holdbac is a lyophilized powdered culture of a strain of Lactobacillus plantarum, sold 
with the expressed purpose of controlling Listeria contamination in dairy. According to the 
technical document supplied by the manufacturer, Danisco, the culture is a weak acidifier, 
targeted for use in cheese products (26). Each laminated foil pouch of Holdbac contains 10 IP 
units of culture totaling approximately 100g of powder. Technical documents state a cell 
concentration of 1109 total lactobacilli/IP. This culture is not presently available for sale in the 
United States and was sourced from the producer in France. This culture likely produces 
pediocin AcH/PA-1, as reported by Rothet al. (2009) (78) and Back et al. (2016) (4), however 
technical details remain proprietary information with the manufacturer. Pediocin AcH/PA-1 is 
fairly well characterized class IIa bacteriocin produced by Pediococcus and Lactobacillus 
species with demonstrated activity towards gram positive organisms such as L. monocytogenes 
(76). 
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Effectiveness of Holdbac against L. monocytogenes has been mainly assessed in surface 
applications. Vytřasová et al. (2010) inoculated the surface of three types of cheese with Listeria 
innocua and applied a 3 IP/L Holdbac treatment to the surface either before or after L. innocua 
inoculation (102). Cheeses were stored at two different temperatures, and L. innocua were 
enumerated over 14 days. L. innocua counts on cheeses were slightly lower when the Holdbac 
treatment was applied before contamination. Log reductions at day 14 from initial inoculation 
levels varied by cheese type and storage temperature, however were reported relative to the 
initial inoculation level and not an internal L. innocua only control (102). In their doctoral thesis 
Emmanuelle Roth demonstrates L. innocua reductions on the surface of semi-hard raclette 
cheese after treatment with Holdbac as part of a smear brine (78). L. innocua was undetectable 
on the surface of the cheese during the entirety of ripening up to day 37 in one trial. Yet in a 
separate trial with a higher inoculation level, no appreciable change from control was observed 
(78). Suitability for L. innocua as a surrogate for L. monocytogenes behavior in cheese 
antimicrobial testing is not well established. 
5.3.4  Lactobacillus plantarum LPAL 
LPAL is a powdered culture of Lactobacillus plantarum manufactured by Sacco Inc 
(Italy) for the purpose of inhibiting unwanted bacteria L. monocytogenes and other Listeria 
species (83). LPAL is applied as a surface treatment to cheese.  
Use of LPAL is not well documented in the literature under its trade name. LPAL was 
used alongside CNBAL in the study of burrata cheese completed by Minervini et al. (2017). 
Addition of the protective culture combination reduced early growth rate of the spoilage 
organisms Staphylococci, coliforms, and Pseudomonas spp (62), but did not assess anti-listerial 
activity. Bacteriocin production is common among L. plantarum strains with many different 
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types reported (25). Frequent isolation of L. plantarum strains with activity towards L. 
monocytogenes suggests LP-AL likely produces a bacteriocin (25, 104) 
5.3.5  Carnobacterium ssp. Lyofast CNBAL 
Lyofast CNBAL is a powdered culture of Gram-positive Carnobacterium species 
manufactured by Sacco Inc (Italy). Manufacturer technical documents state the culture is 
designed to control “unwanted bacteria, like Listeria monocytogenes and generally Listeria spp.” 
on the surface on cheese (81).  
In a series of experiments Spanu et al. (2017, 2018) investigated the used of CNBAL and 
other commercial protective cultures to control surface spoilage development on cheeses 
naturally and artificially contaminated with spoilage species (91, 92). In naturally contaminated 
cheeses treated with CNBAL, lactic acid bacteria counts were lower than other samples. Further, 
Pseudomonas and Enterobacteriaceae counts were one log lower than controls at end of shelf 
life. Difference between treatment and control of counts of these organisms were larger (~>2 
log) at earlier time points (92). Leisner et al. (2007) speculates the lower LAB counts observed in 
these cheeses may be due to poor growth of Carnobacterium in media containing acetate (55). 
MRS, the common media for enumeration of LAB employs sodium acetate as a growth factor for 
Lactobacilli and inhibitor of other species (5). When artificially contaminated with 2 log CFU/g 
of Pseudomonas spp application of CNBAL reduced pseudomonas counts with respect to control 
by 1.28 log at day 14 and 0.83 log at day 21, indicating the potential for control of spoilage 
organisms (91). Both Pseudomonas and Enterobacteriaceae are Gram negative organisms. 
Bacteriocins are commonly only active against bacteria with similar cell morphology, indicating 
a wide range of activity for this culture. 
5.3.6  Enterococcus faecium SF-68 
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SF-68 is a pharmaceutical probiotic culture of Enterococcus faecium, manufactured by 
Cerbios Pharma (70). According to the manufacturer’s website the SF-68 strain Enterococcus 
faecium NCIMB 10415 was isolated in a healthy newborn baby in Sweden (70). According to 
analysis completed by Foulquié-Moreno et al. (2003) SF-68 produces an enterocin. Further 
characterization found no inhibitory activity of SF-68 towards Listeria innocua (37). Use of SF-
68 directly against foodborne pathogens has not been documented, however the probiotic 
properties of SF-68 have been studied extensively (42).  
Other strains of Enterococcus faecium have been investigated in cheese applications for 
production of enterocin and antimicrobial potential. Cheddar cheese was manufactured with E. 
faecium RZS C5 and E. faecium DPC 1146 (38) and bacteriocin activity of cheese throughout 
ripening was characterized by extracting bacteriocins and challenging the extracts to a well 
diffusion assay with a lawn of Listeria innocua LMG13568. Researchers observed zones of 
inhibition in all samples from after the scalding step to 12 months in the first trial and 6 months 
in the second trial, indicating antimicrobial metabolites produced by the culture persisted in the 
cheese.  Sarantinopoulos et al. (2002)  evaluated enterocin production of Enterococcus faecium 
FAIR-E 198 in batch fermentations and then produced feta cheese with the culture (85). 
Researchers did not observe enterocin activity in the cheese, speculating the potential for the 
enterocin to be adsorbed into the cheese matrix. 
5.3.7  Lactococcus lactis ssp. lactis BioSafe-10 
 BioSafe-10 is a frozen pelleted culture of Lactococcus lactis ssp. lactics that is a known 
producer of the well characterized bacteriocin nisin (17). BS-10 is manufactured by Chr Hansen 
and is recommended for application in cheese to control Gram positive bacteria Clostridium sp. 
and Bacillus sp. The culture has a slow acidification rate and is weakly proteolytic (17).  
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Nisin producing strains of Lactococcus lactis ssp. lactis have been used to control pathogens in 
food and cheese with varying degrees of success, however BS-10 lacks documentation under its 
trade name in the literature. Maisnier-Patin et al. (1992) produced Camembert cheese with a pair 
of Lactococcus lactis ssp. lactis strains that produced nisin (57). Lactococcous lactis ssp. lactis 
was inoculated into milk at a concentration of 7 log cfu/g, and grew during manufacture to ~9.5 
log cfu/g before declining to ~6.5 log cfu/g by the end of 6 weeks of ripening. During this same 
time frame nisin titer in both the core and rind of the cheese followed a similar pattern whereby 
the titer peaked at the end of the first day of manufacture and gradually decreased throughout 
ripening. Nisin levels at the surface of the cheese were ~100 IU/g lower than the core curd of the 
cheese. The authors speculated that nisin is labile to proteolytic action of the molds growing at 
the surface and are thus broken down.  
5.3.8  Lactobacillus rhamnosus LRB 
Lyofast LRB is a powdered culture of Lactobacillus rhamnosus, manufactured by Sacco 
Inc (Italy). Manufacturer technical documents state this culture is intended to inhibit bacteria 
such as Listeria spp., yeasts, and molds in fermented milk and cheese products (82). Technical 
documents do not specify the exact bacteriocin produced by this organism. The manufacturer 
also states that this culture may be weakly acidic and may generate aroma from slow citrate 
fermentation (82). The manufacturer designates that the product may also be used as a generic 
probiotic for pharmaceutical purpose and in feed, however limited literature is available 
designating health benefits of this specific strain. 
Documented evaluation of LRB’s antimicrobial properties in the literature is limited, 
although some applications as a probiotic have been published. Minervini et al. (2017) reported 
that burrata cheese manufactured with a combination of LRB and LPAL had lower rates of 
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acidification and reduced counts of staphylococci, coliforms and Pseudomonas spp, (62). Klotz 
et al (2016) investigated the antifungal properties of LRB observing a 46.9% reduction in growth 
rate of common dairy mold Mucor circinelloides (51). In vitro testing of LRB by Schoster  et al. 
(2013) demonstrated inhibition activity towards Clostridium difficile but not C. perfringens in 
broth and agar well diffusion assays (88) . 
5.3.9  Hafnia alvei B16 
B16 is a frozen pelleted culture of Hafnia alvei manufactured by Lallemande (France) for 
the control of Gram-negative organisms in cheese. Presently the mechanism of antagonism is 
unknown, however colicin production has been documented in other strains of Hafnia alvei 
(103). Hafnia alvei is a Gram negative rod of the Enterobacteriaceae family commonly found in 
the environment and intestinal tract of animals and has been isolated from milk (30, 59) and pork 
(34, 90). Isolated cases of opportunistic infection by the organism have been documented (74) 
but it is not of high clinical concern for humans or animals. It can form spores which survive the 
UHT pasteurization, and cause spoilage in UHT milk (16). H. alvei is a strong producer of sulfur 
dioxide gas which raises quality concerns for gas bubbles and early-blowing in the cheese (43). 
As such, the manufacturer advises use with late-ripening type cheeses.  
 The use and efficacy of B16 in milk and cheese has been documented. Delbes-Paus et al. 
(2012) observed 0.8 to 1.4 log reduction of STEC O26 in model cheese made with pasteurized 
milk was co-inoculated with B16 (28). When co-inoculated in model cheese with additional 
microbial consortium representing organisms commonly found in raw milk reductions in STEC 
were enhanced by 0.7 log cfu/g (28). However, no significant reductions in STEC were observed 
when the same cheese was made with raw milk. Callon et al. (2016) later challenged STEC with 
B16 on Saint-Nectaire type cheese. Model cheeses were produced using pasteurized milk 
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inoculated with each of three STEC strains at concentration of 2 log CFU/ml milk and B16 at a 
concentration of 6 log CFU/mL. Inhibitory power (a metric calculated by subtracting the 
treatment value from the control value at the same time point) of B16 in model pressed cheeses 
ranged from 2.6 to 2.0 depending on strain of STEC. When the same cheese was manufactured 
with raw milk, the IP of B16 against STEC strain O26:H11 21765 decreased from 2.4 to 2 (8).  
5.3.10  Staphylococcous xylosus XF01 
XF01 is a powdered culture of Staphylococcous xylosus manufactured by Lallemande for 
the control of Gram positive organisms in cheese. Staphylococcous xylosus is a gram positive, 
coagulase negative bacteria, it is differentiated from the foodborne pathogen Staphylococcous 
aureus which is coagulase positive. Staphylococcous xylosus is a commensal organism on human 
skin and is considered ubiquitous in the farm environment. Commonly isolated in meat and 
dairy, it is employed as a starter in meat fermentations. Staphyloccous xylosus is not considered a 
foodborne pathogen of concern, but cases of opportunistic infection have been documented. 
Antimicrobial work with strains of this species is still emerging. Matikeviciene et al. (2017) 
isolated a bacteriocin-like peptide from a strain of Staphyloccous xylosus which inhibited L. 
monocytogenes  in agar based assays (60). 
6. HYPOTHESIS AND OBJECTIVES 
Based on available published research regarding commercially available protective 
cultures and their ability to inhibit growth of L. monocytogenes and STEC, it was hypothesized 
that PCs exert inhibitory and bactericidal effects against L. monocytogenes and STEC without 
significantly affecting beneficial cheese microbiota and their activity. The specific objectives of this 
research are as follows: 
1. Identify compatible combinations of commercial protective and cheesemaking cultures.  
32 
 
2. Determine the antimicrobial activity of commercial protective cultures against L. 
monocytogenes  
3. Determine the effect of commercial protective cultures on L. monocytogenes and STEC 
during the manufacture and storage of soft-ripened cheese manufactured from raw milk.  
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CHAPTER III 
COMPATIBILITY OF COMMERCIALLY AVAILABLE PROTECTIVE CULTURES 
WITH COMMON CHEESEMAKING CULTURES AND THEIR ANTAGONISTIC 
EFFECT ON FOODBORNE PATHOGENS  
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ABSTRACT 
 The documented survival of food-borne pathogens Listeria monocytogenes (LM) or shiga 
toxin-producing Escherichia coli (STEC) during aging of cheeses made from unpasteurized milk 
highlights the need for additional interventions to enhance food safety. In addition, the Food 
Safety Modernization Act requires that producers implement preventive controls for such 
hazards. However, few validated control strategies compliant with Standards of Identity (SOI) of 
cheese exist. Commercially produced protective cultures (PC) of lactic acid bacteria represent 
actionable natural interventions to control pathogens in cheese, while maintaining compliance 
with SOI. The objective of this study was to identify PCs that exert antimicrobial activity 
towards pathogens with minimal impact on beneficial cheese microflora. Direct antagonism and 
agar well diffusion assays were used to determine the impact of 10 commercially available PCs 
on the growth of starter cultures and cultures of ripening bacteria and fungi. Deferred antagonism 
of PCs towards pathogen cocktails evaluated the potential for use beyond those intended by the 
manufacturer. PCs and starter cultures were co-cultured at 107 CFU/mL each, in UHT milk to 
determine changes in starter culture acid production. Co-cultures were incubated according to a 
simulated cheese-making temperature profile (4 h at 35°C followed by 20 h at 20°C) and the pH 
was measured at 2, 4, 6, 18 and 24 h. Compatibility assays found PC antagonism to be microbe 
and strain specific. A nisin-producing culture of Lactococcus lactis was more antagonistic 
toward growth of thermophilic starters than mesophilic. Antagonism against ripening bacteria 
and fungi was consistent among similar species. One PC negatively impacted the acidification of 
all starters tested. All PCs displayed deferred inhibition of either LM or STEC. This study 
provides data for the compatibility of commercialized PCs with cheesemaking cultures, 
permitting future investigations of their efficacy in cheesemaking scenarios.  
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HIGHLIGHTS 
• Identified nine protective cultures that did not inhibit starter culture growth. 
• Identified seven protective cultures did not impact starter acidification. 
• Inhibition of ripening bacteria and fungi was strain specific. 
• Deferred antagonism of pathogen growth highlights antimicrobial potential.   
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 Unpasteurized (raw) milk and cheeses made from raw milk are linked to a greater 
number of illnesses on a per-consumption basis than pasteurized milk products (21, 28, 38). 
Detection of Listeria monocytogenes (LM) and shiga toxin-producing Escherichia coli (STEC) 
in cheeses made from raw milk (52), as well as recalls (54), and outbreaks of foodborne infection 
resulting in hospitalizations and death (7, 11, 26), highlights the need for additional pathogen 
control strategies for fermented dairy products and cheeses made from raw milk. Current 
regulation specifies cheeses made from unpasteurized milk be aged for at least 60 days at 
≤1.67°C (35°F) as an alternative to pasteurization. Documentation of pathogen survival in cheese 
beyond 60 days of aging suggests additional controls would enhance the safety of these products 
(13). Requirements introduced by the Food Safety Modernization Act (FSMA) set a higher 
standard of accountability for the safety of food products. FSMA requires food processors, 
including cheesemakers, to develop food safety plans that identify and manage hazards 
associated with their product. The use of protective bacterial cultures is one potential approach.  
Protective cultures (PCs) of lactic acid bacteria (LAB) have been isolated from a variety 
of foods and shown to produce a host of antimicrobial metabolites such as organic acids and 
bacteriocins as non-specific defense against competitors (12). Cultures of LAB are generally 
recognized as safe (GRAS) based on their historic use in food fermentations whereas purified 
bacteriocin preparations require additional testing before GRAS approval (29, 36). Furthermore, 
the Standards of Identity (SOI) for Cheese and Cheese Products outlined in 21 CFR §133 (8), 
which protect the product from adulteration and misbranding, exclude the use of most 
antimicrobial agents allowed in other food products. Although the SOI limit the use of 
bacteriocin preparations to select cheeses (20), the same active compounds are allowed if 
produced in situ. The antimicrobial activity of laboratory strains of PCs for the control of 
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pathogens and spoilage organisms has been demonstrated both in culture media as well as in 
dairy and other food applications (35, 40). However, data on the antimicrobial activity and 
compatibility of commercially available cultures are limited. Commercial cultures are available 
to producers and are often screened for desirable attributes including flavor or aroma production, 
acidification rate, resistance to food enzymes, and substrate compatibility. Adjunct cultures have 
long been used in cheesemaking to provide additional flavor and physical properties to a cheese 
(2, 46), however such adjuncts must be compatible with starter and ripening cultures (22). 
Commercialized PCs currently  available to producers are limited with specific intended 
applications in meat (51), dairy (19, 47), and seafood (43).  The potential for cross-product (e.g. 
salami and cheese) and cross-pathogen (e.g. L. monocytogenes and Salmonella) is not well 
documented.   
The objectives of this study were to screen commercially available protective cultures 
against foodborne pathogens of concern and to characterize their compatibility with common 
starter and ripening cultures of bacteria and fungi used in cheesemaking.  
MATERIALS AND METHODS 
Culture preparation. Starter cultures, ripening bacteria, yeasts and molds were selected to 
include those commonly used in the cheese industry to produce a variety of cheese types. 
Mesophilic starter cultures (MSC) (RA21, MA11, MA4001, MM100, and KAZU), thermophilic 
starter cultures (TSC) (TA54, TA61, and TM8), ripening bacteria (MGE, LR, SR1, and SR3), 
ripening yeast (CUM, KL, and DH), and both surface (GEO17, ABL, HP5, Neige, and VB) and 
internal (PA, PJ, PS, and PV) ripening molds were all produced by Danisco-Dupont (New Century, 
KS) and purchased through Dairy Connection Inc. (Madison, WI) (Table S1). Commercially 
produced protective cultures used in the present study are intended for controlling STEC in 
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cheese, LM in dairy (e.g., cheese surface) or meats, and spoilage microorganisms in dairy 
including cheese. Strains included Lactococcus lactis subsp. lactis DVS BS-10 (LLN), 
Pediococcus acidiliacticii B-LC-20 (PA), Lactobacillus curvatus B-LC-48 (LC) (Chr. Hansen 
Inc., Milwaukee, WI), Lactobacillus plantarum (LPP) Holdbac Listeria (Danisco USA Inc, New 
Century, KS), Lactobacillus rhamnosus Lyofast LRB (LR), Lactobacillus plantarum Lyofast 
LPAL (LP), Carnobacterium spp. Lyofast CNBAL (CD) (Sacco,  Cadorago CO, Italy), 
LALCULT Protect Hafnia alvei B16 (HA), LALCULT Protect Staphylococus xylosus XF01 
(Lallemand Specialty Cultures, Rhinelander, WI), and Enterococcus faecium SF68 (EF) 
(NCIMB 10415, Cerbios-Pharma SA, Barbengo, Switzerland) (Table S2). All cultures were 
stored according to manufacturer recommendations. Working PC cultures were prepared for use 
by inoculating cultures directly in either 0.1% peptone water (BD, Franklin Lakes, NJ) or UHT 
milk to achieve the desired counts (CFU/mL) for use in the assays below. Working cultures were 
mixed for 15 s then allowed to hydrate at room temperature for 30 m before use. Counts were 
confirmed following serial dilution in 0.1% peptone water, plating on de Man Rogosa Sharpe 
(MRS) agar (BD) and incubation at 30°C for 48 h. Hafnia alvei counts were confirmed using 
plate count agar supplemented with 1% skim milk powder (Price Chopper New York, NY), 
5mg/L vancomycin (Fisher Scientific, Hampton, NH), and 5mg/L crystal violet (Fisher 
Scientific) after incubation at 30°C for 48 h as described by Delbus et al. (2013) (17).  S. xylosus 
(SX) counts were confirmed on Baird Parker agar (BD) incubated at 37° for 48 h. Working 
cheese cultures were prepared in 0.1% peptone. MSC were enumerated on MRS as described for 
PCs whereas TSC were incubated anaerobically (10% CO2, 90% N2) at 42°C for 48 h. Ripening 
bacteria were enumerated on tryptic soy agar (BD) supplemented with 0.6% yeast extract (BD). 
Fungal cultures were propagated in sterile UHT milk (Natrel, Price Chopper, Schenectady, NY) 
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at 25°C for five days. Then, 100 μL were spread onto Sabouraud dextrose agar (SDA) (BD) and 
incubated at 25°C for 7 days. Spore suspensions were harvested by applying 10 mL of sterile 
deionized water with 0.5% Tween 80 (Fisher Scientific) and dislodging spores from mycelia 
with a sterile glass rod (Corning, Corning, NY). Spore concentrations were confirmed with a 
hemocytometer (Hausser Scientific, Horsham, PA). 
A cocktail containing six strains of LM selected from milk and cheese-related outbreaks 
was prepared (CWD 675-3: Hispanic-style cheese-related outbreak, DJD1: washed rind cheese-
related outbreak, ATCC 51414: milk-related outbreak, Scott A: milk-related outbreak, 2012L-
5323: ricotta salata cheese-related outbreak, 2014L-6025: Hispanic style cheese-related 
outbreak). The cocktail of non-O157 STEC included six strains representing each of the six 
major serogroups (O26:H11 NRRL B-59821, O103:H2 NRRL B-59827, O45:H2 NRRL B-
59823, O121:H19 03-2832 NRRL B-59834, O145:NM 03-4699 NRRL B-59836, and O111:NM 
94-0961). The cocktail of STEC O157:H7 included six strains from various sources 
(EC2:Gouda, 7927: Apple cider, 0016: milk, ATCC 700599: Salami, Odwalla, EDL933: ground 
beef outbreak). Frozen (-80°C) stock cultures of each pathogen were inoculated individually into 
9 mL of tryptic soy broth with 0.6% yeast extract added (TSBYE) (BD) for E. coli or brain heart 
infusion broth (BHI) (BD) for Listeria. Cultures were incubated at 37°C for 18 h for two 
subsequent transfers before use. For each pathogen, equal proportions of cells from each culture 
were combined as a cocktail.  The resulting cocktail was pelleted through centrifugation (4,000  
g for 15 min at 4°C) (Thermo Scientific Sorvall Legend X1R, ThermoFisher Scientific, 
Waltham, MA), and re-suspended in an equal volume of 0.1% peptone. 
Direct antagonism of starter and ripening bacteria. Direct antagonism was determined 
according to the method described by Barefoot and Klaenhammer (1983) (3) with minor 
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modification. Briefly, 1 mL of MRS agar (1.5% agar) was added to individual wells of 12-well 
tissue-culture treated plates (Corning Costar, Corning, NY). Bacterial cultures were prepared as 
previously described to achieve 9 log CFU/mL. Wells were spotted with 3 μL of PC and the 
plates were allowed to dry for 15 m in a biosafety cabinet. Soft MRS agar (0.75% agar), seeded 
with starter, ripening, or protective cultures at 7 log CFU/mL, was then applied (750 μL) as an 
overlay. Plates were covered and incubated aerobically at 35°C for 48 h for MSC and 42°C for 
48 h for TSC. Definitive zones of inhibition were measured using electronic calipers (Fisher 
Scientific) and antagonism was defined as follows: (-) no antagonism observed, no zone; (+) 
slight antagonism, diffuse clearing or 0-3 mm zone; (++) moderate antagonism, 3-6.25 mm zone; 
(+++) significant antagonism, 6.25+ mm zone (48). 
Deferred antagonism of pathogens. Deferred antagonism was determined according to the 
method described by Coeuret et al. (2004) with minor modification (10). Briefly, 5 μl of PC in 
MRS at 9 log CFU/mL were spotted onto MRS agar and allowed to dry in a biosafety cabinet for 
30 m. Then 7 mL of soft (0.3%) MRS agar was overlaid on the surface and plates were incubated 
at 30°C for 24 h. Following incubation, plates were overlaid with 7 mL of soft (0.3%) TSBYE 
seeded with a target pathogen at 7 log CFU/mL. Plates were incubated at 37°C for 24 h. 
Following incubation, definitive zones of inhibition and final spot diameters were measured 
using electronic calipers.  The effective inhibition ratio (EIR) was calculated to compare relative 
antimicrobial activity following the equation provided by Coeuret et al. (2004). The difference 
between the diameters of the zone of clearing and the PC spot was divided by the diameter of the 
PC spot (10). An EIR value above 1 indicates the diameter of the zone of clearing exceeded the 
diameter of the spot which produced it. The EIR value is zero in the absence of a zone of 
clearing.  
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Direct antagonism of fungi. Direct antagonism of fungi was determined according to the 
method described by Inglin et al. (2015) (25).  Briefly, 24-well cell-culture plates (Corning 
Costar) containing 300 μl of either BHI (for cultures HA and SX) or MRS (for all other PCs) 
were spot-inoculated with 0.75 μl of PC cell suspensions as previously described and incubated 
for 48 h at 35°C. Wells were then overlaid with 100 μl of soft SDA (0.5% agar) seeded with 3-4 
log fungal spores/mL. Plates were incubated at 25°C and inhibition relative to control was 
visually recorded daily for 7 days on a four-point scale as follows: (-) no antagonism observed; 
(+) slight antagonism, growth less dense than control; (++) moderate antagonism, growth 
markedly weaker or less dense than control but still present; (+++) significant antagonism, 
complete inhibition of growth.  
Agar well diffusion assay. Indirect antagonism was determined using a standard well 
diffusion assay as described by Ryan et al. (1996) (44). Overnight cultures of PCs incubated in 
MRS broth at 35°C were centrifuged (15 min, 4000 x g, 4°C) and supernatants were collected. 
Subsamples of each PC supernatant were neutralized to pH 7 with 1N NaOH (Fisher Scientific). 
Both un-neutralized and neutralized supernatants were filter-sterilized (0.22 μm, Fisher 
Scientific) to obtain cell-free supernatants (CFS). Cheese cultures were serially diluted in 0.1% 
peptone and added to molten soft (0.5% agar) MRS agar (for starter cultures) or TSAYE (for 
ripening bacteria) to achieve 7 log CFU/mL and poured into sterile petri plates. Once the agar 
had solidified, 8 mm diameter wells were aseptically removed and 50 μL of neutralized or un-
neutralized CFS was added in duplicate. Zones of inhibition were measured using electronic 
calipers after 24 h of incubation at either 42°C (TSC), 35°C (MSC), or 30°C (ripening bacteria).   
Co-culture acidification. Stock cultures of PCs and SCs were prepared in UHT whole 
milk as previously described. Equal volumes (5 mL) of cultures were combined such that each 
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was present at 7 log CFU/mL. Un-inoculated milk was used as a negative control and individual 
PCs or SCs alone served as positive controls. Cultures were incubated statically at 35°C for 4 h, 
then 20°C for 20 h to simulate the temperature profile of a cheesemaking process. Samples were 
removed for pH measurements prior to incubation (0) and then during incubation at 2, 4, 18, and 
24 h. 
Statistical analysis. The antagonism and agar well diffusion assays were performed in 
triplicate on three different days using independently propagated cultures with technical 
replicates per treatment. For agar well diffusion assay, radii of zones of inhibition measured from 
technical duplicates were averaged for each trial. Co-culture acidification assays were performed 
in triplicate on three different days using independently propagated cultures with technical 
replicates per treatment.  pH measurements from technical replicates were averaged for each 
treatment-time point.  Data were analyzed using the PROC MIXED procedure of SAS 9.4 (SAS 
Institute Inc., Cary, NC) to determine the effects of treatment, time, and treatment × time 
interactions on pH. Covariance structure AR (1) was used for repeated measures. Pairwise 
comparisons were performed using LSMEANS with the Tukey-Kramer method.  
RESULTS AND DISCUSSION 
Inhibition of starter culture growth. Nine of the 10 PCs tested did not inhibit growth of 
MSC or TSC in direct antagonism assays (Table 2). LLN was the only PC that inhibited growth 
of both MSC and TSC, with TSC being the most sensitive. The mesophilic LLN culture is a 
known producer of nisin, which is a well characterized bacteriocin of the class I lantibiotics.  
Optimal temperatures for cell growth and nisin production differ (37 and 30°C, respectively) and 
are strain dependent (9). Despite incubation at non-optimal temperature for nisin production by 
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LLN, thermophiles were still markedly inhibited. This suggests that S. thermophilus has an 
increased susceptibility to nisin. This agrees with the results of previous studies that 
demonstrated enhanced antimicrobial activity of nisin and nisin variants against TSC compared 
to MSC (18, 42). S. thermophilus and other TSC are acid sensitive and intracellular activity 
responsible for cell growth and metabolism is inhibited or lost at or below pH of <5.5 (4). 
Therefore, co-production of organic acids by LLN could enhance the overall antimicrobial effect. 
Agar well diffusion results agreed with those of the direct antagonism assay, whereby LLN 
demonstrated an inhibitory effect against all the starter cultures tested (Table 3). Both the 
neutralized and un-neutralized supernatants from LLN were inhibitory to all starter cultures 
tested, indicating that antimicrobial activity is not entirely pH dependent and is most likely 
attributed to nisin production. 
Starter cultures can contain mixtures of both thermophilic and mesophilic bacteria in 
proprietary proportions (Supplemental Table 1). Therefore, the degree of antagonism may not be 
uniform across all strains in the mixture. This may limit the ability of this assay to identify 
potential effects of PC antagonism on cheese technology. For example, S. thermophilus, 
identified as sensitive to nisin, is added to many mixed cultures including MM4001 for flavor 
production late in cheese aging due to autolysis of the culture. Inhibition of S. thermophilus in a 
mixed culture by nisin might not be detected by this assay but could impact final cheese flavor 
by arresting growth and activity of this specific culture. Additional studies on individual strains 
in mixtures would be needed to identify more specific culture compatibility.  
The absence of direct antagonism of starter cultures in the presence of PCs could partially 
be explained by production of acid by the starters, a low relative abundance of antimicrobial 
metabolites produced by the PC, or limits to the range of bacteriocin activity. Lactic acid 
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bacteria, while isolated from high-acid environments and known for their ability to produce 
lactic acid, are considered neutrophiles and are not well adapted for growth at low pH (24). Acid 
tolerance systems have been observed to abate antagonism of Lactococcus lactis from multiple 
stresses (39), but induction of these systems would not be expected within the short timeframe of 
cheesemaking. As such, production and accumulation of organic acids by starter cultures or PCs 
could inhibit starter culture growth. Additionally, most starter cultures, with the exception of 
select strains of lactobacilli and lactococci, do not produce the enzyme catalase to neutralize 
hydrogen peroxide (14) and would be susceptible to any localized peroxide production by PCs. 
Finally, the range of bacteriocin activity is narrow. Bacteriocins produced by Gram positive 
bacteria exert antimicrobial activity by disrupting the cell membrane either through inhibiting 
membrane synthesis or forming pores causing cell contents to leak. While limited reports of 
bacteriocin activity towards both Gram negative and Gram positive bacteria exist (15, 32),  
bacteriocin activity is typically limited to the cell wall type of the bacteriocin producer (1). This 
may partially explain the absence of activity of HA on Gram positive starter cultures observed 
here. 
Inhibition of ripening bacteria. Growth of Arthrobacter nicotianae (MGE) was affected 
by all PCs except LR, with the largest zones of inhibition observed when grown with LLN. 
Sensitivity of MGE to the SX culture is notable as these two species are frequently found co-
inhabiting cheese rind communities (6). The CFS from six PCs, including LLN, inhibited MGE 
in the agar well diffusion assay, indicating inhibition was not dependent on PCs directly, but 
rather their production of inhibitory metabolites. Brevibacterium linens cultures (LR, SR1, and 
SR3) were only mildly inhibited by several PCs including PA, LC, LPP, and LP. Variation 
among these cultures allows cheesemakers to optimize color, growth rate, and proteolytic 
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activity for flavor production in the final cheese. However, similarities in sensitivity to PCs 
suggests that specific trial-and-error testing in each cheese and specific ripening bacteria may be 
necessary to ensure ripening is not inhibited in cheese made with these PCs. B. linens strains 
have been found to produce the bacteriocins linecin or linocin, but susceptibility to other 
bacteriocins has not been well characterized (34, 53). Ripening cultures MGE, SR1, and SR3 
were less sensitive to the un-neutralized CFS of LR, suggesting a partial effect of acid produced 
by this culture. None of the ripening cultures tested, including Gram negative MGE, were 
sensitive to supernatants of Gram negative HA, despite inhibition in the direct assay. This is in 
agreement with data from the manufacturer that the mechanism of action is not believed to be a 
function of bacteriocin or acid production. Together, these results suggest potential compatibility 
of all PCs except LLN with these commercial ripening cultures. Tables 2 and 4 provide reference 
for the compatibility of commercially produced PCs and common cheesemaking cultures. 
Inhibition of protective cultures. Previous studies have identified the potential for 
synergy among laboratory strains of protective cultures (37) but not those that are commercially 
produced. Screening this panel for inhibition between cultures is the first step towards 
identifying the potential for synergistic combinations. Protective cultures LLN and HA inhibited 
the growth of nearly all other PCs except themselves and each other. The probiotic culture EF 
was inhibited by all cultures except itself and SX. The SX culture was inhibited by PA, LC, LLN 
and HA and was the second most sensitive of the PCs tested. These results indicate that LLN, 
HA, SX, and EF are not good candidates for combinatory approaches. 
Inhibition of pathogens. Deferred antagonism, as measured by a zone of clearing and 
calculated effective inhibition ratio (EIR) value, was observed for all PC-pathogen combinations 
(Table 3). Lb. plantarum LPP demonstrated the highest measurable activity towards both Gram 
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negative and Gram positive pathogens with EIRs >2.6. Similar results were reported by Coeurt et 
al. (2004) (10), for laboratory strains of probiotic lactobacilli against strains of L. 
monocytogenes. While LPP had the largest EIR value, CD, and LR had statistically similar 
values to LPP. All cultures with the exception of LPP shared a statistical grouping, indicating the 
pronounced activity of LPP.  Antimicrobial activity against E. coli was strain dependent with 
EIRs ranging from 0 to 2.8. EIR values of multiple PCs were statistically similar for both O157 
and non-O157 STEC, indicating similarity in extent of inhibition. Culture HA and EF had the 
lowest values of the panel and shared a statistical grouping while L. plantarum cultures LP and 
LPP, as well as CD and LR or LC and SX  had the largest EIR values and shared groupings for 
non-O157 and O157 STEC respectively. EIR values reported in the present study for O157 and 
non-O157 STEC all exceeded 1, suggesting potential antimicrobial activity for all PCs against 
these pathogens. As mentioned previously, antagonistic activity can in part be attributed to the 
production of multiple metabolites including organic acids, hydrogen peroxide, and bacteriocins 
that diffuse into the agar layer prior to the growth of the indicator. Steps to neutralize hydrogen 
peroxide or acidity were not taken (23). Given the cell wall specificity of bacteriocins mentioned 
previously, antagonism observed could be partially attributed to these metabolites. 
Inhibition of fungi. Antagonism of fungi was strain dependent (T), whereby nine of the 
10 PCs demonstrated antifungal activity against at least one of the 12 fungal cultures. 
Debaryomyces hansenii (DH) was the only yeast tested whose growth was visibly affected by 
PCs. Substantial inhibition was observed on day four with PA, LPP, LP, and LR and slight 
inhibition with CD and EF. Strom et al. (2001) observed inhibition of D. hansenii when treated 
with the supernatant of L. plantarum MiLAB393 that they attributed to specific cyclo-dipeptides 
(49). A study by Magnusson et al. (2003), reported on the selective antifungal activity of 
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multiple L. plantarum isolates towards some, but not all, yeasts or molds (33, 45). Yeasts 
neutralize the pH at the surface of the cheese to allow for subsequent succession by a community 
of molds and bacteria, depending on the cheese type (50). Reduced growth in response to the 
presence of PCs could disrupt community development. As a result delays in ripening or 
development of niches for less-desirable organisms could impact both quality and safety.  
Surface ripening molds, including Penicillium candidum, are responsible for flavor and 
texture development of cheese (27, 30). PCs PA, LPP, CD, LP, LR showed slight or intermediate 
inhibitory effects against most P. candidum cultures. Cultures ABL and Neige were both 
completely inhibited by LPP, but ABL recovered with slight growth observed through the 
remaining days of observation. This suggests that use of LPP could impact rind development and 
ripening if used in conjunction with these cultures. One intended use for LR is for the control of 
unwanted yeast and mold. This culture was partially inhibitory to five of the 12 fungal cultures 
tested and did not completely inhibit any. Geotricum candidum GEO17 was the only surface 
culture not susceptible to any of the PCs tested. This agrees with the results reported by Salas et 
al. (2018) on the resistance of G. candidum to a panel of LAB isolates (31).  
P. roqueforti imparts characteristic color, flavor, and texture to blue cheeses. Because P. 
roqueforti cultures can differ in growth rate, salt tolerance, enzyme production and color, 
multiple mold cultures are commonly used to modulate ripening and produce desirable qualities 
in the final cheese. Only HA and SX showed slight antagonism towards P. roqueforti cultures 
PA, PJ, and PV. The degree of inhibition reported was often due to the density of the culture 
when compared to control rather than color or absence of growth. Slight inhibition observed did 
not advance in extent beyond day four, suggesting metabolites produced by the PC persisted in 
the media preventing mold regrowth or recovery. The resulting matrix presented in T could be 
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used to anticipate potential antifungal activity when selecting cultures to avoid negative impacts 
on in surface community development and ripening. 
Impact of PCs on acidification activity of starters. A starter culture’s primary role in 
cheesemaking is the conversion of lactose into lactic acid, which aids curd development and 
contributes to the safety of the product. Even mild inhibition of acidification by PCs endangers 
product quality, consistency, and safety if pH-time targets are not met. Overall, no significant 
treatment effects or treatment and time interactions were identified for 56 of 80 co-culture 
combinations. In other words, seven of the 10 PCs did not impact the acidification of common 
starters at all, while LP and LLN only impacted the acidification of one starter each. Significant 
treatment and time interactions and significant treatment effects were observed for 22 of the 
remaining combinations. Mean pH values were not significantly different at any time point for 
15 of this 22 combination subset. The remaining seven combinations for which pH values at one 
or more time points differed from control are displayed in Table 6. Significant treatment effects 
were identified for the combinations of MA11 and LPP and MA4001 and LP. LPP impacted the 
acidification of all MSC and TSC with pH values higher than control as incubation time 
progressed (Table 6). This suggests that products may fail to meet acidification targets when 
used with this culture at the recommended dose of ~7 log CFU/mL. Initial decreases in pH 
following the addition of LPP could be attributed to the lower cell counts per unit of culture that 
necessitates the addition of more product by weight. The greater amount of added material 
(carrier/fermentate) in the same volume of milk also contributed to visual and textural 
differences in the stock solution compared to other PCs. Oumer et al. (2001) reported that the 
acidification potential of TSCs was more readily impacted in the presence of PCs than that of 
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MSCs (42). They concluded that using PCs as an adjunct to MSCs is more feasible than with 
TSCs. Data presented here follow a similar pattern and support this conclusion. 
Acid production by PCs in UHT milk alone was strain specific, but most did not decrease 
pH by more than 1 unit over 24 h incubation through the cheesemaking gradient. Cultures LPP, 
LP, and LLN produced the greatest reductions in pH at 1.47, 0.95, and 1.4 units, respectively. 
The difference in pH from the starting value of each PC treatment was less than 0.3 pH unit at 
the four hour time point for all PCs except LPP (-0.35 lower than control), LP (-0.35), LLN (-
0.52), and HA (-0.33). For comparison, cheesemaking starter cultures had reduced pH of UHT 
milk by ~1.5 units at the 4h time point and total decrease of ~2 units by the 24 h point. These 
data suggest that while select PCs can contribute to the acidification of milk, it is neither at the 
same rate nor to the same extent as the starter cultures. Starter culture activity is vital throughout 
the cheese make process, but is especially critical early on. Based on these data, acidification is 
most likely attributed to the starter at early time points and that acid development by select PCs 
will be additive, potentially accelerating a cheese make provided PC activity does not inhibit 
growth of the starter when combined.   
Manufacturer technical documentation, direct antagonism and agar well diffusion assays 
suggested the potential for LLN to prevent growth of starter cultures. However, co-culture pH 
data indicate that there is little impact of LLN on the acidification potential of most starter 
cultures at this inoculation level. Overall, these results suggest LLN could be safely used in a 
cheese application and therefore will be a candidate in further testing. In contrast, co-cultures 
with LPP had a significant effect on the acidification of several starter cultures at the 
recommended inoculation level despite no indication of inhibition in agar-based assays. Previous 
studies in milk (42), yogurt (16) and cheese (5, 41, 42) have demonstrated a strain-dependent 
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impact of PC on starter acidification. Although cultures are generally compatible, the potential 
for strain specific interactions underscores the importance of screening new cultures for 
compatibility and to determine acceptable inoculation levels.  
In summary, most of the commercially available PCs screened in the present study did 
not inhibit cheesemaking starter growth or acidification potential. Inhibition of ripening bacteria, 
yeasts and molds by PCs was mixed and strain specific. More testing is needed in cheese models 
to confirm compatible use of PCs in specific applications. Limited cross-reactivity between PCs 
identifies combinations of PCs that could be used in combination for potential synergistic effects. 
Additional studies are needed to confirm the antimicrobial activity of PCs against target 
pathogens and optimize inoculation parameters for antimicrobial effect without disrupting 
culture activity under specific conditions of use.  
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TABLES 
 
TABLE 1. Direct antagonism of cheesemaking cultures by protective cultures  
 
 Degree of Inhibition by Protective Cultures 
Culture 
PA LC LPP LP CD EF LLN LR HA SX 
Mesophilic 
Starter 
Cultures 
RA21 - - - - - - + - - - 
MA11 - - - - - - + - - - 
MA4001 - - - - - - + - - - 
MM100 - - - - - - + - - - 
KAZU - - - - - - +++ - - - 
Thermophilic 
Starter 
Cultures 
TA54 - - - - - - +++ - - - 
TA61 - - - - - - +++ - - - 
TM81 - - - - - - +++ - - - 
Ripening 
Bacteria 
MGE 
+ + + + + + +++ - + + 
LR 
++ + ++ ++ - - - - +++ - 
SR1 ++ + ++ ++ - - - - - - 
SR3 + + ++ + + - - - - - 
 Degree of Inhibition: (-) No Inhibition Observed– No Zone; (+) Slight Inhibition – Diffuse 
Clearing, or 0-3 mm Zone ; (++) Moderate Inhibition- 3-6.25 mm Zone; (+++) Significant 
Inhibition- 6.25+ mm Zone.   
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TABLE 2. Direct antagonism of protective cultures  
 Degree of Inhibition by Protective Cultures 
Culture PA LC LPP LP CD EF LLN LR HA SX 
PA - - - - - - ++ - ++ - 
LC - - - - - - ++ - ++ - 
LPP - - - - - - + - ++ - 
LP - - - - - - + - ++ - 
CD - - - - - - ++ - ++ - 
EF + + + + + - + + + - 
LLN - - - - - - - - - - 
LR - - - - - - + - + - 
HA - - - - - - - - - - 
SX + + + - + - + - + - 
Degree of Inhibition: (-) No Inhibition Observed– No Zone; (+) Slight Inhibition – Diffuse 
Clearing, or 0-3 mm Zone; (++) Moderate Inhibition- 3-6.25 mm Zone; (+++) Significant 
Inhibition- 6.25+ mm Zone.  
PA: Pediococcus acidilactici B-LC-20, LC: Lactobacillus curvatus BLC-48, LPP: Lb. plantarum 
Holdbac, LP: Lactobacillus plantarum Lyofast LPAL, CD: Carnobacterium divergens CNBAL, 
EF: Enterococcus faecium SF68, LLN: Lactococcus lactis ssp. lactis BS-10, LR: Lb, rhamnosus 
Lyofast LRB, HA: Hafnia alvei B16, SX: Staphylococcus xylosus XF01 
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TABLE 3. Inhibition of cheesemaking cultures by neutralized (N) and un-neutralized (U) cell free supernatants of protective cultures 
  Degree of Inhibition by Protective Cultures 
Starter Culture/ 
Ripening Bacteria 
PA  LC  LPP  LP  CD  EF  LLN  LR  HA  SX 
U N  U N  U N  U N  U N  U N  U N  U N  U N  U N 
Mesophilic 
Starter 
Cultures 
RA21 - -  - -  - -  - -  - -  - -  + +  - -  - -  - - 
MA11 - -  - -  - -  - -  - -  - -  ++ ++  - -  - -  - - 
MA4001 - -  - -  - -  - -  - -  - -  + +  - -  - -  - - 
MM100 - -  - -  - -  - -  - -  - -  + +  - -  - -  - - 
KAZU - -  - -  - -  - -  - -  - -  + +  - -  - -  - - 
Thermophilic 
Starter 
Cultures 
TA54 - -  - -  - -  - -  - -  - -  ++ ++  - -  - -  - - 
TA61 - -  - -  - -  - -  - -  - -  ++ ++  - -  - -  - - 
TM81 - -  - -  - -  - -  - -  - -  ++ ++  - -  - -  - - 
Ripening 
Bacteria 
MGE + +  - -  ++ +  + +  + +  - -  + +  + -  - -  - - 
LR - -  - -  - -  - -  - -  - -  ++ ++  + -  - -  - - 
SR1 - -  - -  + -  - -  - -  - -  + +  + -  - -  - - 
SR3 - -  - -  - -  - -  - -  - -  + +  - -  - -  - - 
Degree of Inhibition: (-) no zone; (+) 1 to 5mm; (++) 5 to 15mm; (+++) 15 mm and over.  
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TABLE 4. Direct antagonism of pathogens by protective cultures 
 Effective Inhibition Ratio1 
Pathogen  PA LC LPP LP CD EF LLN LR HA SX 
Non-O157 STEC  1.92 ± 0.11b 1.74 ± 0.30bc 2.62 ± 0.62a 1.98 ± 0.22ab 1.64 ± 0.08ab 1.46 ± 0.04c 1.32 ± 0.14bc 1.97 ± 0.13ab 1.39 ± 0.15c 1.86 ± 0.14b 
STEC O157 1.77 ± 0.33bc 2.13 ± 0.22ab 2.65 ± 0.08a 2.09 ± 0.21ab 1.72 ± 0.24bc 1.38 ± 0.13c 1.64 ± 0.41bc 1.86 ± 0.34bc 1.35 ± 0.10c 1.96 ± 0.14abc 
LM2 2.31 ± 0.19b 1.87 ± 0.04b 3.14 ± 0.19a  2.28 ± 0.15b 2.41 ± 0.13ab 1.36 ± 0.32b 1.86 ± 0.17b 2.60 ± 0.22ab 1.29 ± 0.32b 2.26 ± 0.56b 
Means within a row with the same letter are not significantly different  
1Effective Inhibition Ratio (EIR) was calculated as the difference between the diameters of the zone of clearing and the PC spot, 
divided by the diameter of the PC spot. 
2 LM: Listeria monocytogenes 
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TABLE 5 Degree of inhibition of fungi by protective cultures relative to control 
 Fungal Culture 
Degree of inhibition by Protective Culture 
PA LC LPP LP CD EF LLN LR HA SX 
Yeasts CUM - - - - - - - - - - 
KL71 - - - - - - - - - - 
DH ++ - ++ ++ + + - ++ - - 
Surface Molds  GEO17 ++ - +++ ++ + - - ++ + - 
ABL - - - - - - - - - - 
HP6 ++ - ++ ++ + - - + - - 
Neige ++ - +++ ++ - - - ++ + - 
VB ++ - ++ ++ + - - ++ - - 
Internal Molds  PA - - - - - - - - + + 
PJ - - - - - - - - + + 
PS - - - - - - - - - - 
PV - - - - - - - - + + 
Degree of Inhibition: (-) Uninhibited- Same Amount of Growth (Density of coverage) as control; 
(+) Slight Inhibition- Weakened Growth relative to control; (++) Substantial Inhibition- Slight 
amount of growth relative to control; (+++) Complete Inhibition- No Growth compared to 
control. 
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TABLE 6. pH Values (mean +/- SD) of UHT milk incubated at a cheesemaking temperature 
profile with cheesemaking starter cultures alone or with protective cultures. 
Treatment  
Mean pH  
2h  4h  18h  24h 
 
RA21 4.86 ± 0.29 
 
4.56 ± 0.13 
 
4.27 ± 0.15 
 
4.26 ± 0.12 
 
RA21 + LPP 5.59 ± 0.20 
 
5.48 ± 0.19 * 4.99 ± 0.08 
 
4.82 ± 0.05 
 
MA11 4.68 ± 0.03 
 
4.65 ± 0.24 
 
4.21 ± 0.09 
 
4.23 ± 0.13 
 
MA11 + LPP 5.49 ± 0.12 
 
5.32 ± 0.10 
 
4.96 ± 0.03 
 
4.92 ± 0.14 
 
MA4001 5.01 ± 0.10  4.79 ± 0.05  4.36 ± 0.07  4.35 ± 0.03  
MA4001 + LPP 5.55 ± 0.13 * 5.46 ± 0.17 * 5.03 ± 0.08 * 4.85 ± 0.01 * 
MA4001 + LP  5.02 ± 0.11  4.73 ± 0.05  4.22 ± 0.03  4.15 ± 0.01  
MM100  4.94 ± 0.07 
 
4.72 ± 0.09 
 
4.33 ± 0.09 
 
4.36 ± 0.07 
 
MM100 + LPP 5.53 ± 0.13 * 5.40 ± 0.14 * 4.97 ± 0.06 * 4.82 ± 0.02 * 
KAZU 5.51 ± 0.08 
 
4.97 ± 0.21 
 
4.36 ± 0.03 
 
4.28 ± 0.03 
 
KAZU + LPP 5.61 ± 0.11 
 
5.48 ± 0.13 * 4.96 ± 0.07 * 4.78 ± 0.03 * 
TA54 5.36 ± 0.33  4.87 ± 0.31  4.49 ± 0.19  4.43 ± 0.26  
TA54 + LPP 5.61 ± 0.26  5.37 ± 0.29  4.79 ± 0.12  4.66 ± 0.06  
TA54 + LLN 5.90 ± 0.27  5.30 ± 0.27 * 4.71 ± 0.15  4.61 ± 0.19  
TA61 5.17 ± 0.31  4.64 ± 0.25  4.27 ± 0.07  4.22 ± 0.14  
TA61 + LPP 5.67 ± 0.24  5.42 ± 0.20 * 4.73 ± 0.10  4.56 ± 0.08  
TM81  5.23 ± 0.22  4.60 ± 0.16  4.32 ± 0.02  4.30 ± 0.05  
TM81 + LPP 5.78 ± 0.16 * 5.45 ± 0.24 * 4.82 ± 0.12 * 4.67 ± 0.04  
Within a column* designates value is significantly different (P <0.05) from respective control 
LPP: Lb.  plantarum Holdbac, LP: Lb.  plantarum LPAL, LLN: Lc. lactis ssp lactis BS-10 
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SUPPLEMENTARY TABLES 
TABLE S1. Danisco cheesemaking cultures used, Sourced from Dairy Connection 
Culture 
Name 
Species Culture Details 
RA21 Lactococcus lactis ssp. 
lactis  
Lc. lactis ssp. cremoris  
Streptococcus salivarius 
ssp. thermophilus 
Mesophilic culture, fast acidification 
MA11 Lc. lactis ssp. lactis  
Lc. lactis ssp. cremoris 
Mesophilic heterofermentative cultures 
MA4001 Lc. lactis ssp. lactis  
Lc. lactis ssp. cremoris 
Lc. lactis ssp. lactis 
biovar diacetylactis 
S. thermophilus 
Heterofermentative farmhouse cultures with a 
mesophilic predominance 
MM100 Lc. lactis ssp. lactis  
Lc. lactis ssp. cremoris 
Lc. lactis ssp. lactis 
biovar diacetylactis 
Aromatic acidifying mesophilic culture,  
KAZU  Lc. lactis ssp. lactis  
Lc. lactis ssp. cremoris 
Lc. lactis ssp. lactis 
biovar diacetylactis 
Lactobacillus helveticus 
Mesophilic heterofermentative farmhouse cultures 
adapted to farmer productions, equal balance of strains 
TA54 S. thermophilus Thermophilic culture 
TA61 S. thermophilus Thermophilic “cooked cheese” culture 
TM81 S. salivarious ssp. 
thermophilus 
Lb. delbrueckii ssp. 
bulgaricus 
Thermophilic, rapid acidification for cheese with high 
dry matter 
MGE Arthrobacter nicotianae Ripening Bacteria 
LR Brevibacterium linens   Ripening Bacteria 
SR1 B. linens   Ripening Bacteria 
SR3 B. linens Ripening Bacteria 
CUM Candida utilis Yeast 
KL71 Kluyvermyces lactis Yeast 
DH Debaromyces hansenii Yeast 
GEO17 Geotrichum candidum Surface Yeast/mold hybrid 
ABL Penicillium candidum Surface Mold 
HP6 P. candidum Surface Mold 
NEIGE P. candidum Surface Mold 
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VB P. candidum Surface Mold 
PA P. roqueforti Internal Mold 
PJ P. roqueforti Internal Mold 
PS P. roqueforti Internal Mold 
PV P. roqueforti Internal Mold 
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TABLE S2: Commercially available protective cultures 
Manufacturer Trade Name Internal  
Code 
Organism (s) Manufacturer Intended Purpose 
Chr. Hansen BLC-20 PA Pediococcus acidilactici LM1 control in meat  
Chr. Hansen BLC 48 LC Lactobacillus curvatus Minimize LM on bacon 
Danisco Holdbac LPP Lactobacillus plantarum LM control in dairy 
SACCO LPAL LP Lactobacillus plantarum Surface treatment for LM on cheese 
SACCO CNBAL CD Carnobacterium divergens ssp. Surface treatment for LM on cheese 
Cerbios Pharma SF68 EF Enterococcus faecium Pharmaceutical probiotic 
Chr. Hansen BS-10 LLN Lactococcus lactis ssp lactis Control of Gram + : 
Clostridium sp, Bacillus sp. 
SACCO LRB LR Lactobacillus rhamnosus Inhibit LM, yeast, molds 
Lallemand 
Lalccult 
B16 HA Hafnia alvei STEC control in milk 
Lallemand Lalccult XF01 SX Staphylococcus xylosus LM control in milk 
1 –Listeria monocytogenes 
  
74 
 
TABLE S3: pH (mean +/- SD) of UHT milk incubated at a cheesemaking temperature profile 
with cheesemaking starter cultures alone or with protective cultures. 
  Mean pH 
Treatment 0h 2h 4h 18h 24h 
RA21 Control 5.96 ± 0.62 4.86 ± 0.29 4.56 ± 0.13 4.27 ± 0.15 4.26 ± 0.12  
PA 6.37 ± 0.15 4.89 ± 0.28 4.59 ± 0.21 4.31 ± 0.17 4.26 ± 0.04  
LC 6.35 ± 0.19 4.95 ± 0.35 4.61 ± 0.24 4.34 ± 0.16 4.23 ± 0.02  
LPP 6.01 ± 0.21 5.59 ± 0.20 5.48 ± 0.19 4.99 ± 0.08 4.82 ± 0.05  
LP 6.34 ± 0.21 5.03 ± 0.42 4.61 ± 0.27 4.25 ± 0.12 4.12 ± 0.03  
CD 6.35 ± 0.23 4.98 ± 0.39 4.62 ± 0.25 4.36 ± 0.16 4.31 ± 0.05  
EF 6.34 ± 0.21 5.00 ± 0.35 4.62 ± 0.25 4.33 ± 0.15 4.28 ± 0.05  
LLN 6.26 ± 0.29 4.94 ± 0.29 4.57 ± 0.21 4.31 ± 0.12 4.29 ± 0.09  
LR 6.29 ± 0.29 5.03 ± 0.39 4.61 ± 0.24 4.30 ± 0.13 4.27 ± 0.09  
HA 6.28 ± 0.30 5.04 ± 0.44 4.64 ± 0.27 4.39 ± 0.15 4.30 ± 0.11  
SX 6.35 ± 0.33 5.06 ± 0.46 4.61 ± 0.25 4.34 ± 0.11 4.28 ± 0.08 
MA11 Control 5.89 ± 0.68 4.68 ± 0.03 4.65 ± 0.24 4.21 ± 0.09 4.23 ± 0.13  
PA 5.94 ± 0.46 4.84 ± 0.22 4.47 ± 0.06 4.22 ± 0.05 4.14 ± 0.01  
LC 5.93 ± 0.36 4.69 ± 0.03 4.49 ± 0.01 4.27 ± 0.08 4.19 ± 0.01  
LPP 5.86 ± 0.26 5.49 ± 0.12 5.32 ± 0.10 4.96 ± 0.03 4.92 ± 0.14  
LP 5.94 ± 0.48 4.74 ± 0.07 4.47 ± 0.05 4.12 ± 0.05 4.10 ± 0.04  
CD 5.90 ± 0.52 4.74 ± 0.06 4.49 ± 0.04 4.25 ± 0.06 4.21 ± 0.04  
EF 5.97 ± 0.46 4.74 ± 0.05 4.50 ± 0.05 4.24 ± 0.02 4.21 ± 0.07  
LLN 5.86 ± 0.52 4.72 ± 0.05 4.45 ± 0.06 4.26 ± 0.02 4.24 ± 0.07  
LR 5.88 ± 0.44 4.73 ± 0.03 4.48 ± 0.08 4.21 ± 0.03 4.21 ± 0.08  
HA 5.94 ± 0.42 4.70 ± 0.07 4.47 ± 0.08 4.24 ± 0.03 4.24 ± 0.03  
SX 5.88 ± 0.46 4.67 ± 0.06 4.48 ± 0.05 4.24 ± 0.01 4.24 ± 0.06 
MA4001 Control 6.24 ± 0.16 5.01 ± 0.10 4.79 ± 0.05 4.36 ± 0.07 4.35 ± 0.03  
PA 6.23 ± 0.04 4.97 ± 0.15 4.74 ± 0.13 4.35 ± 0.04 4.31 ± 0.05  
LC 6.26 ± 0.12 5.02 ± 0.09 4.76 ± 0.04 4.38 ± 0.03 4.33 ± 0.05  
LPP 5.96 ± 0.17 5.55 ± 0.13 5.46 ± 0.17 5.03 ± 0.08 4.85 ± 0.01  
LP 6.20 ± 0.09 5.02 ± 0.11 4.73 ± 0.05 4.22 ± 0.03 4.15 ± 0.01  
CD 6.25 ± 0.15 5.02 ± 0.11 4.76 ± 0.05 4.38 ± 0.03 4.37 ± 0.06  
EF 6.24 ± 0.10 5.02 ± 0.14 4.75 ± 0.06 4.36 ± 0.03 4.34 ± 0.02  
LLN 6.15 ± 0.19 4.95 ± 0.10 4.71 ± 0.06 4.38 ± 0.03 4.35 ± 0.04  
LR 6.20 ± 0.15 5.03 ± 0.10 4.75 ± 0.05 4.35 ± 0.02 4.31 ± 0.05  
HA 6.16 ± 0.13 5.02 ± 0.12 4.75 ± 0.04 4.38 ± 0.02 4.36 ± 0.01  
SX 6.30 ± 0.20 4.99 ± 0.10 4.75 ± 0.04 4.39 ± 0.02 4.36 ± 0.03 
MM100 Control 6.17 ± 0.31 4.94 ± 0.07 4.72 ± 0.09 4.33 ± 0.09 4.36 ± 0.07 
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  Mean pH 
Treatment 0h 2h 4h 18h 24h  
PA 6.18 ± 0.15 4.91 ± 0.10 4.67 ± 0.04 4.34 ± 0.03 4.35 ± 0.08  
LC 6.15 ± 0.05 4.91 ± 0.11 4.67 ± 0.04 4.32 ± 0.07 4.32 ± 0.08  
LPP 5.95 ± 0.19 5.53 ± 0.13 5.40 ± 0.14 4.97 ± 0.06 4.82 ± 0.02  
LP 6.16 ± 0.20 4.98 ± 0.09 4.68 ± 0.04 4.20 ± 0.03 4.15 ± 0.02  
CD 6.09 ± 0.15 4.92 ± 0.10 4.66 ± 0.09 4.32 ± 0.06 4.31 ± 0.04  
EF 6.14 ± 0.22 4.96 ± 0.05 4.69 ± 0.02 4.33 ± 0.04 4.31 ± 0.03  
LLN 6.10 ± 0.28 4.95 ± 0.09 4.68 ± 0.04 4.37 ± 0.03 4.33 ± 0.03  
LR 6.17 ± 0.24 4.99 ± 0.10 4.71 ± 0.03 4.34 ± 0.02 4.31 ± 0.02  
HA 6.11 ± 0.25 4.98 ± 0.13 4.71 ± 0.04 4.37 ± 0.02 4.34 ± 0.01  
SX 6.17 ± 0.33 5.00 ± 0.17 4.72 ± 0.05 4.39 ± 0.02 4.35 ± 0.03 
KAZU Control 6.47 ± 0.10 5.51 ± 0.08 4.97 ± 0.21 4.36 ± 0.03 4.28 ± 0.03  
PA 6.50 ± 0.07 5.40 ± 0.10 4.89 ± 0.02 4.34 ± 0.05 4.28 ± 0.02  
LC 6.39 ± 0.07 5.38 ± 0.21 4.88 ± 0.03 4.33 ± 0.05 4.28 ± 0.06  
LPP 6.06 ± 0.04 5.61 ± 0.11 5.48 ± 0.13 4.96 ± 0.07 4.78 ± 0.03  
LP 6.39 ± 0.04 5.48 ± 0.04 4.90 ± 0.08 4.23 ± 0.05 4.18 ± 0.06  
CD 6.45 ± 0.06 5.53 ± 0.03 4.93 ± 0.09 4.36 ± 0.03 4.36 ± 0.05  
EF 6.44 ± 0.07 5.52 ± 0.08 4.94 ± 0.12 4.38 ± 0.03 4.31 ± 0.02  
LLN 6.33 ± 0.04 5.36 ± 0.13 4.84 ± 0.05 4.44 ± 0.01 4.34 ± 0.01  
LR 6.40 ± 0.04 5.44 ± 0.04 4.90 ± 0.04 4.33 ± 0.03 4.26 ± 0.04  
HA 6.35 ± 0.07 5.39 ± 0.12 4.93 ± 0.06 4.38 ± 0.03 4.31 ± 0.03  
SX 6.48 ± 0.11 5.56 ± 0.33 4.99 ± 0.22 4.38 ± 0.00 4.31 ± 0.06 
TA54 Control 6.71 ± 0.23 5.36 ± 0.33 4.87 ± 0.31 4.49 ± 0.19 4.43 ± 0.26  
PA 6.64 ± 0.26 5.47 ± 0.51 5.01 ± 0.32 4.54 ± 0.26 4.42 ± 0.22  
LC 6.66 ± 0.14 5.62 ± 0.37 5.11 ± 0.23 4.61 ± 0.22 4.51 ± 0.24  
LPP 6.16 ± 0.10 5.61 ± 0.26 5.37 ± 0.29 4.79 ± 0.12 4.66 ± 0.06  
LP 6.70 ± 0.14 5.71 ± 0.20 5.18 ± 0.24 4.54 ± 0.05 4.46 ± 0.08  
CD 6.70 ± 0.17 5.90 ± 0.27 5.30 ± 0.27 4.71 ± 0.15 4.61 ± 0.19  
EF 6.67 ± 0.12 5.84 ± 0.21 5.19 ± 0.18 4.68 ± 0.15 4.60 ± 0.13  
LLN 6.49 ± 0.04 5.95 ± 0.16 5.50 ± 0.01 4.87 ± 0.02 4.69 ± 0.14  
LR 6.64 ± 0.15 5.72 ± 0.30 5.03 ± 0.19 4.50 ± 0.11 4.52 ± 0.19  
HA 6.62 ± 0.14 5.64 ± 0.19 5.13 ± 0.15 4.73 ± 0.17 4.61 ± 0.23  
SX 6.60 ± 0.14 5.56 ± 0.22 5.06 ± 0.18 4.68 ± 0.17 4.64 ± 0.14 
TA61 Control 6.76 ± 0.22 5.17 ± 0.31 4.64 ± 0.25 4.27 ± 0.07 4.22 ± 0.14  
PA 6.72 ± 0.33 5.30 ± 0.24 4.71 ± 0.16 4.30 ± 0.10 4.27 ± 0.08  
LC 6.60 ± 0.17 5.47 ± 0.39 4.87 ± 0.18 4.35 ± 0.14 4.34 ± 0.13  
LPP 6.13 ± 0.04 5.67 ± 0.24 5.42 ± 0.20 4.73 ± 0.10 4.56 ± 0.08  
LP 6.60 ± 0.28 5.63 ± 0.51 4.78 ± 0.30 4.27 ± 0.11 4.20 ± 0.06  
CD 6.66 ± 0.37 5.72 ± 0.71 4.89 ± 0.38 4.37 ± 0.16 4.31 ± 0.11 
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  Mean pH 
Treatment 0h 2h 4h 18h 24h  
EF 6.61 ± 0.37 5.58 ± 0.49 4.78 ± 0.25 4.32 ± 0.11 4.30 ± 0.09  
LLN 6.56 ± 0.33 5.39 ± 0.33 4.77 ± 0.22 4.34 ± 0.12 4.29 ± 0.10  
LR 6.60 ± 0.36 5.53 ± 0.56 4.75 ± 0.20 4.29 ± 0.09 4.31 ± 0.09  
HA 6.57 ± 0.38 5.36 ± 0.41 4.70 ± 0.22 4.33 ± 0.13 4.32 ± 0.17  
SX 6.56 ± 0.37 5.21 ± 0.40 4.58 ± 0.22 4.31 ± 0.08 4.29 ± 0.10 
TM81 Control 6.91 ± 0.19 5.23 ± 0.22 4.60 ± 0.16 4.32 ± 0.02 4.30 ± 0.05  
PA 6.93 ± 0.20 5.28 ± 0.29 4.61 ± 0.15 4.32 ± 0.03 4.36 ± 0.07  
LC 6.85 ± 0.17 5.41 ± 0.22 4.72 ± 0.13 4.38 ± 0.04 4.37 ± 0.05  
LPP 6.25 ± 0.06 5.78 ± 0.16 5.45 ± 0.24 4.82 ± 0.12 4.67 ± 0.04  
LP 6.84 ± 0.17 5.52 ± 0.33 4.67 ± 0.20 4.21 ± 0.04 4.15 ± 0.03  
CD 6.90 ± 0.19 5.58 ± 0.50 4.74 ± 0.21 4.35 ± 0.05 4.34 ± 0.06  
EF 6.92 ± 0.18 5.49 ± 0.40 4.69 ± 0.18 4.34 ± 0.03 4.42 ± 0.11  
LLN 6.72 ± 0.16 5.46 ± 0.19 4.84 ± 0.24 4.43 ± 0.08 4.41 ± 0.09  
LR 6.87 ± 0.19 5.43 ± 0.40 4.66 ± 0.16 4.30 ± 0.02 4.31 ± 0.06  
HA 6.82 ± 0.20 5.39 ± 0.31 4.68 ± 0.16 4.37 ± 0.04 4.33 ± 0.07  
SX 6.84 ± 0.15 5.24 ± 0.36 4.60 ± 0.14 4.34 ± 0.02 4.32 ± 0.03 
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SUPPLEMENTAL FIGURE S1: Representative images of inhibition in culture based 
compatibility assays completed 
Direct Antagonism Assay 
 
Agar Well Diffusion 
 
Anti-Fungal Assay 
 
Top Row: Measureable 
Inhibition (Zones of 
Clearing)  
 
Middle/Bottom Rows: No 
Zones 
Top Row: Measureable 
Inhibition (Zones of 
Clearing)  
 
Middle Row: Control Wells 
(No Addition, No Zone) 
 
Bottom Row: No Zones 
Top Row Score: 
 +++/-/+++/++/-/- 
Second Row Score: 
 +++/-/+++/++/-/none 
Third Row Score:  
-/-/++/+/-/-  
Fourth Row Score:  
-/-/++/+/-/none 
 
Last column alternate 
untreated positive controls 
and media negative controls 
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CHAPTER IV 
FATE OF LISTERIA MONOCYTOGENES IN RAW MILK CO-INOCULATED WITH  
COMMERCIALLY AVAILABLE PROTECTIVE CULTURES 
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ABSTRACT 
Listeria monocytogenes (LM) is a significant hazard in the production of cheese when 
using unpasteurized milk. Commercially produced protective cultures (PC) of lactic acid bacteria 
represent actionable natural interventions to control this and other pathogens in cheese.  The 
objective of this study was to determine the efficacy of five PCs to control the growth of L. 
monocytogenes in raw milk when co-inoculated and exposed to a typical cheese-making 
temperature profile. Raw milk inoculated with a six-strain cocktail of LM at ~2 log CFU/mL was 
incubated overnight at 4°C. Freeze dried protective cultures were added directly to contaminated 
raw milk the following morning at ~7 log CFU/mL. Raw milk containing both pathogen and PC 
were then incubated under a simulated cheesemaking temperature profile consisting of 4 h at 
35°C followed by 18 h at 20°C, and an additional five days at 12°C. LM growth in the control 
exceeded 4 log CFU/mL after the 24h of the cheesemaking gradient and reached a high of 5.44 
log CFU/mL 120h after inoculation. Impact of cultures on LM growth varied. Two cultures did 
not impact LM growth while two cultures exerted a bacteriostatic effect and one culture reduced 
and maintained LM concentration in milk to <1 log CFU/mL starting 24h after addition. This 
work demonstrates the effectiveness of select PCs for the control of LM in an intended dairy 
matrix (raw milk) and under simulated use parameters (temperature and time). Differences in 
effectiveness based on pathogen and culture inoculation method inform future applications in the 
production of raw milk cheese and other fermented dairy products made from raw milk.  
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Human pathogen Listeria monocytogenes (LM) has been isolated from raw milk (25), 
detected in the farm dairy processing environment (1, 14), and finished raw milk cheese products 
(13, 23). The organism is capable of growing at refrigerator temperatures and is of significant 
public health concern due to high case fatality rates (4). Implementation of the Food Safety 
Modernization Act now mandates that cheesemakers anticipate and manage biological hazards 
such as LM in their product using preventive controls as part of a comprehensive food safety 
plan. However, scientifically validated controls compliant with the Standards of Identity of 
Cheese are limited, impeding compliance with FSMA.   
Potential for biological control of LM using laboratory strains of protective cultures 
(PCs) has been well established in the scientific literature (5, 20); however validation of 
commercially available cultures as a process control in raw milk dairy applications is limited as 
validation studies are infrequently published with trade names. PCs are considered Generally 
Recognized as Safe (GRAS) for use in food products, due to historic use in safe and successful 
food fermentations. Protective cultures of lactic acid bacteria exert protective antimicrobial 
activity in a food product through the production of metabolites such as organic acids, hydrogen 
peroxide, and antimicrobial peptides known as bacteriocins (5). Metabolite production is a 
bacterial defense mechanism towards similar bacteria attempting to occupy the same ecological 
niche. Due to the generic nature, specificity of metabolite activity is not limited to a single 
species; however bacteriocin activity is frequently limited to bacteria sharing the same cell wall 
morphology as the producer (7). In addition to application in dairy, commercially available 
strains of protective cultures are available for quality and safety enhancement in meat (22), 
seafood (11), and produce (19). Commercialized cultures are selected for desirable antimicrobial 
activity in intended matrix, however cross protection is possible (6). Therefore, validation of 
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commercially available cultures (with both intended and undocumented use in dairy) under 
expected use conditions of cheesemaking is a critical first step towards expanding process 
control options available to raw milk cheese makers to manage pathogen risk. 
Here, a panel of five commercially available protective cultures intended for LM control 
in dairy and meat applications were assessed for anti-listerial potential in the presence of raw 
milk consortia over time-temperature conditions emulating of cheesemaking. Cultures were 
selected based on results from previous anti-listerial activity testing in our lab using BHI broth 
and UHT milk (data not shown) in combination with compatibility results discussed previously. 
Culture selections had demonstrated anti-listerial activity in the milk and culture media and did 
not inhibit starter culture acidification. The most effective culture(s) identified from this proof-
of-concept screen will be used for further validation of activity in raw milk cheese. 
MATERIALS AND METHODS 
Bacterial cultures and cocktail preparation. Five commercial cultures were selected 
from the panel used in compatibility analysis (Chapter III) using results of previous anti-
pathogenic screening completed in our lab.  Cultures were of Lactococcus lactis ssp. lactis 
BioSafe-10 (LLN),  Pediococcus acidilactici B-LC-20 (PA) (Chr. Hansen Inc., Milwaukee, WI), 
Lactobacillus plantarum Lyofast LPAL (LP), Lactobacillus rhamnosus Lyofast LRB (LR) 
(Sacco, Cadorago CO, Italy), and Lb. plantarum Holdbac (LPP) (Danisco USA Inc, New 
Century, KS). As per manufacturer recommendations, direct vat set (DVS) format culture LLN 
was stored at -80°C prior to use, powdered lyophilized cultures were stored at -20°C.  Cultures 
were added directly to milk to achieve a target count of ~7 log CFU/mL. Cell counts for all PCs 
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were confirmed following serial dilution in 0.1% peptone (BD-Difco, Franklin Lakes, NJ), 
plating onto de Man Rogosa Sharpe agar (MRS) (BD), and incubation at 30°C for 48 h.  
A six strain cocktail of Listeria monocytogenes was prepared with strains associated with 
dairy-related outbreaks of listeriosis including: ATCC 51414 (raw milk); CWD 675-3 (raw 
milk); Scott A; 2012L-5323 (Ricotta Salata); 2014L-6025 (Hispanic-style cheese); and DJD 1 
(washed-rind cheese) (10). Frozen (-80°C) stock cultures were inoculated individually into 9 mL 
of brain heart infusion broth (BHI) (BD). Cultures were incubated at 37°C for 18 h for two 
subsequent transfers before use. Equal proportions of cells from each culture were combined as a 
cocktail.  The resulting cocktail was pelleted through centrifugation (4,000  g for 15 min at 4°C) 
(Thermo Scientific Sorvall Legend X1R, ThermoFisher Scientific, Waltham, MA), and re-
suspended in an equal volume of 0.1% peptone yielding ~9 log CFU/mL.   
Milk Collection. Raw milk was aseptically collected from the bulk tank at the Kellogg 
Dairy center at the University of Connecticut in sterilized 1L Duran flasks (Fisher Scientific), 
transported to the lab within 30m of collection and stored at 4°C for use within 72h. Each batch 
of milk was screened for presence of L. monocytogenes (LM) according to the methods outlined 
in the FDA Bacterial Analytical Manual (9). Briefly, 25mL samples were enriched in 225mL 
Buffered Listeria Enrichment Broth at 30°C for 4 h followed by 44h of selective enrichment at 
30°C. Aliquots of 100μL were streaked onto CHROMagar Listeria, incubated for 48h at 37°C, 
and examined for the presence of typical colonies (teal in color surrounded by a halo).   
Co-Culture Assay. LM cocktail prepared as described previously was serially diluted in 
raw milk and added to 30 mL of raw milk in dilution bottles (Corning, Corning NY) to a target 
count of 2 log CFU/mL. Bottles were stored at 4°C for ~18h to mimic storage of contaminated 
milk prior to cheesemaking. The following morning, PC stocks were prepared in raw milk as 
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described and inoculated in milk to a final count of 7 log CFU/mL. Duplicate bottles of each PC 
were prepared. Duplicate bottles of raw milk as well as raw milk inoculated with LM alone or 
PC alone were included as controls. 
Bottles were mixed at the time of each addition and prior to sampling by shaking the 
bottle in a vertical 10 inch arc for 10 seconds. Bottles were incubated statically at 35°C for 4h 
then were equilibrated to room temperature (~22°C) for 20h prior to storage at 12°C for another 
5 days. This time and temperature profile was selected to emulate the time-temperature exposure 
conditions for cheese making, and pressing and ripening (24). The pH of samples were 
determined at the time of LM inoculation, PC inoculation (0 h), at each temperature change (4, 
24, and 48h), and then daily (72, 96, 120, and 144h) thereafter. 
Bacterial Enumeration. Samples of milk were removed for enumeration at the same 
time points described for pH. Peptone water (0.1%) was used for all serial dilutions. Samples 
were plated onto CHROMagar Listeria for enumeration of LM and MRS for the enumeration of 
total mesophilic lactic acid bacteria. Typical colonies were counted after incubation at 30°C or 
37°C for 48h for MRS and CHROMagar Listeria, respectively.  
Statistical Analysis. Mean values of pH, mesophilic LAB counts and pathogen counts 
were generated from three independent replicates with technical duplicates. Data were analyzed 
using the PROC MIXED procedure of SAS 9.4 (SAS Institute Inc., Cary, NC) with repeated 
measures to determine the effects of treatment, time, and treatment × time interactions for each 
variable. Pairwise comparisons were performed using LSMEANS with the Tukey-Kramer 
method. Compound Symmetry was used as a covariance structure for repeated measures. 
Significance was assessed at P ≤ 0.05. 
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RESULTS & DISCUSSION 
Population of mesophilic lactic acid bacteria in co-culture. Mean counts of mesophilic 
lactic acid bacteria (Table 1) were determined to confirm PC inoculation levels and observe 
changes over time. Concentration of mesophilic LAB of the raw milk did not change throughout 
overnight storage then increased from 1.37 log CFU/mL to 6.78 log CFU/mL over the first 24h. 
LAB counts of raw milk continued to increase throughout refrigerated storage until a population 
of 8.8 log CFU/mL was reached at 96h after which point the population did not change. No 
differences in lactic counts between LM and RM controls were observed.  PC growth was not 
inhibited by endogenous microflora, likely a result of their predominance in the mixture (7 log 
CFU/mL). Lactic counts in co-cultures and respective PC controls did not differ at any time point 
after PC addition. Lactic counts in co-cultures with LR, PA, or LPP decreased by <1 log 
CFU/mL from the time of inoculation through four hours of incubation at 35°C. In contrast, LM 
counts in co-cultures of LLN and LP increased slightly. This suggests that cultures vary in their 
ability to quickly adapt to, and grow in, the milk environment. Total LAB counts in all 
treatments exceeded 8 log CFU/mL after 24h of incubation and did not differ from one another 
through the remainder of the storage.  
Behavior of Listeria monocytogenes in co-culture. All raw milk samples were negative 
for the presence of LM. Inoculated LM counts did not increase from the time of inoculation 
through overnight storage (Time 0) at 4°C (Figure 1). Similarly, counts did not increase during 
the initial 4h incubation at 35°C. LM counts in control increased by 2 log CFU/mL during the 
subsequent 20h at room temperature, and reached a mean count of 5.44 log CFU/mL by the end 
of observation (144h). These changes in counts are similar to those reported for LM growth in 
raw milk under a similar time-temperature scheme (12). Absence of growth during the 4 h 
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incubation at 35°C to emulate “cheesemaking” could be attributed to the lag phase of Listeria 
monocytogenes. Reports indicate strain dependent lag phases as short as 24h in autoclaved skim 
milk (18) and as long as 7 h in TSBYE (2). Competitive exclusion (16) or antimicrobial 
compounds (15, 21) produced by autochthonous microorganisms could also extend the lag phase 
of LM when in a mixed culture such as raw milk and limit overall growth.  
LM counts in co-culture with LR or PA did not differ from control at any time point. LR 
is intended for use to control LM, yeasts, and mold in cheese. Previous work in our lab identified 
LR as an effective LM control (3), absence of activity here could indicate interaction with raw 
milk microbiota. Under conditions tested here, these data suggest that this culture would not be 
effective in controlling LM during the manufacture of raw milk cheese. This, however, would 
have to be confirmed in a cheese model. Although the culture of PA is intended for the control of 
LM in meat fermentations, our results suggest that this application may not extend to dairy 
fermentations.  
Mean counts of LM in the LP and LPP treatments were similar at each time point 
indicating that these different cultures of Lb. plantarum are similarly effective in inhibiting the 
growth of LM under the conditions tested. Lb. plantarum strains have been shown to produce 
both plantaricins and pediocins that have bacteriostatic to bactericidal potential (8). LPP is a 
pediocin producing culture according to the manufacturer. The inhibition of LM by LPP could 
also be attributed to pH as the pH of LPP co-cultures was significantly lower than other 
treatments from inoculation of the culture through 48 h of incubation (Table 2). Differences in 
culture concentration necessitated that a greater quantity of LPP culture to be added compared to 
other treatments. An immediate reduction in milk pH was observed upon addition of the larger 
quantity of culture. The difference in quantity of culture required to produce the intended 
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antimicrobial benefit could be costly for a cheesemaker and is likely to significantly impact 
cheesemaking technology. 
LLN reduced LM counts to levels below that of the initial inoculation within the first 24 
h of incubation. Regrowth of LM to levels above inoculation was not observed. This culture of 
Lc. lactis is intended for the control Gram positive spoilage microorganisms, namely spore-
forming species of Bacillus and Clostridium, LLN has been identified by its manufacturer as a 
producer of the bacteriocin nisin. Nisin activity is enhanced at low pH (17). Consistent with 
results observed in pH co-culture experiments in chapter III of this work, incubation of milk with 
LLN resulted in slight reductions in milk pH over time (Table 2). However, reductions in pH 
were similar to those observed with less efficacious cultures, suggesting that pH alone was not 
responsible for LM reductions, and LM reductions were likely due to strong nisin production. 
While the LLN culture was observed to inhibit growth of cheesemaking starter cultures in culture 
media, it was not excluded from further testing here because culture addition did not impact 
starter culture acid production. This characteristic combined with anti-listerial activity observed 
make it a viable candidate for further testing in cheese manufacture.  
These results demonstrate the varying efficacy of commercial PCs to control L. 
monocytogenes in raw milk incubated through a cheesemaking time and temperature profile. 
While acidity provides a hurdle, the ability of PCs to control LM growth is dependent upon the 
cultures ability to produce antimicrobial metabolites in the presence of raw milk consortia. While 
previous work identified the potential for LLN culture to inhibit starter culture growth, that same 
work showed it did not impact acidification activity of the starters. This suggests that it can be 
used in cheesemaking. Positive compatibility results in combination with the strong anti-listerial 
activity suggests the LLN culture is the most promising PC for future studies in cheese. 
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TABLES AND FIGURES 
TABLE 1. Mean mesophilic LAB counts (±SD) in raw milk co-inoculated with LM (2 log CFU/mL) and Protective Cultures (7 log 
CFU/mL). 
Means within a column with the same letter are not significantly different; columns without letters were not significantly different 
RM: Raw milk control, LM: L. monocytogenes cocktail control, PA: Pediococcus acidilactici B-LC-20, LR: Lactobacillus rhamnosus 
Lyofast LRB, LP: Lactobacillus plantarum Lyofast LPAL, LPP: Lb. plantarum Holdbac, LLN: Lactococcus lactis ssp. lactis BS-10.  
  
  Mesophilic LAB count  
Treatment Inoculation with 
LM 
0 h 4 h 24 h 48 h 72 h 96 h 120 h 144 h 
RM 1.37 ± 0.35 1.37 ± 0.35a 3.38 ± 0.84a 6.72 ± 1.54 7.30 ± 1.51 8.32 ± 0.52 8.80 ± 0.24 8.82 ± 0.18 8.86 ± 0.15 
LM 1.72 ± 0.46 1.67 ± 0.56a 3.47 ± 0.77a 6.65 ± 1.36 7.19 ± 1.69 8.51 ± 0.21 8.86 ± 0.25 8.72 ± 0.19 8.79 ± 0.17 
PA 1.40 ± 0.09 6.97 ± 0.13bc 6.86 ± 0.28bc 7.98 ± 0.17 8.33 ± 0.41 8.62 ± 0.12 8.74 ± 0.16 8.80 ± 0.19 8.78 ± 0.04 
PA+LM 1.94 ± 0.27 7.10 ± 0.15bc 7.04 ± 0.24bc 8.08 ± 0.21 8.38 ± 0.43 8.62 ± 0.21 8.79 ± 0.10 8.90 ± 0.11 8.86 ± 0.11 
LR 1.36 ± 0.24 6.65 ± 0.25bc 6.65 ± 1.05bc 8.03 ± 0.11 8.50 ± 0.23 9.01 ± 0.40 8.87 ± 0.20 8.84 ± 0.05 8.90 ± 0.18 
LR+LM 1.92 ± 0.42 6.53 ± 0.18b 5.70 ± 0.69c 8.31 ± 0.31 8.51 ± 0.21 8.58 ± 0.25 8.87 ± 0.08 8.88 ± 0.09 8.94 ± 0.22 
LP 1.48 ± 0.18 7.27 ± 0.08bc 7.47 ± 0.57bc 7.95 ± 0.10 8.54 ± 0.25 8.66 ± 0.44 8.89 ± 0.19 8.90 ± 0.04 8.87 ± 0.18 
LP+LM 1.91 ± 0.39 7.24 ± 0.09bc 7.53 ± 0.39bc 7.99 ± 0.09 8.54 ± 0.22 8.40 ± 0.39 9.02 ± 0.15 8.85 ± 0.14 8.83 ± 0.30 
LPP 1.42 ± 0.25 6.54 ± 0.10b 6.24 ± 0.67bc 8.44 ± 0.23 8.86 ± 0.10 8.94 ± 0.10 8.99 ± 0.14 8.79 ± 0.08 8.92 ± 0.07 
LPP + LM 1.92 ± 0.38 6.55 ± 0.02b 5.96 ± 0.15c 8.38 ± 0.18 8.76 ± 0.34 8.91 ± 0.15 8.97 ± 0.19 8.89 ± 0.08 9.03 ± 0.06 
LLN 1.28 ± 0.47 7.56 ± 0.37bc 8.06 ± 0.36b 8.11 ± 0.11 8.38 ± 0.18 8.63 ± 0.15 8.89 ± 0.16 8.91 ± 0.08 8.92 ± 0.06 
LLN + LM 1.85 ± 0.26 7.44 ± 0.35bc 8.01 ± 0.21b 8.28 ± 0.13 8.37 ± 0.24 8.65 ± 0.28 9.00 ± 0.08 9.04 ± 0.05 8.91 ± 0.03 
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TABLE 2.  pH (± SD) of raw milk co-cultured with LM and Protective Cultures. 
  pH  
 Inoculation 
with LM 0 h 4 h 24 h 48 h 72 h 96 h 120 h 144 h 
RM 6.73 ± 0.07 6.76 ± 0.03 a 6.73 ± 0.03 ab 6.56 ± 0.09 a 6.16 ± 0.14 a 5.99 ± 0.40 ab 6.00 ± 0.21 a 5.85 ± 0.21 ab 5.51 ± 0.46a 
LM 6.73 ± 0.05 6.77 ± 0.05 a 6.74 ± 0.03 a 6.56 ± 0.09 a 6.16 ± 0.14 a 6.11 ± 0.25 a 6.04 ± 0.26 a 5.88 ± 0.22 a 5.62 ± 0.36a 
PA+LM 6.76 ± 0.06 6.72 ± 0.03 a  6.61 ± 0.03 abcde 6.38 ± 0.10 ab 5.51 ± 0.45 bdc 4.99 ± 0.42 ab 4.94 ± 0.55 abc 4.91 ± 0.80 abc 4.48 ± 0.15ab 
LR+LM 6.75 ± 0.05 6.75 ± 0.03 a 6.59 ± 0.21 ace 6.48 ± 0.06 ab 6.07 ± 0.03 ab 6.06 ± 0.09 ab 5.88 ± 0.13 ab 5.64 ± 0.45 bc 5.51 ± 0.59a 
LP+LM 6.75 ± 0.08 6.77 ± 0.02 a 6.55 ± 0.03 abcd 6.24 ± 0.04 abc 5.96 ± 0.06 dc 5.55 ± 0.32 dc 5.20 ± 0.53 cd 4.91 ± 0.41 c 4.58 ± 0.08c 
LPP + LM 6.75 ± 0.04 6.36 ± 0.03 b 6.44 ± 0.24 f 5.93 ± 0.15 d 5.08 ± 0.06 e 4.92 ± 0.19 d 4.91 ± 0.41 d 4.93 ± 0.66 c 4.62 ± 0.31bc 
LLN + LM 6.72 ± 0.07 6.75 ± 0.02 a 6.65 ± 0.07 ef 6.48 ± 0.09 bc 5.82 ± 0.41 abc 5.78 ± 0.52 bc 5.68 ± 0.57 bcd 5.52 ± 0.74 c 5.42 ± 0.81bc 
 
Means within a column with the same letter did not differ (P > 0.05). 
 
RM: Raw milk control, LM: L. monocytogenes cocktail control, PA: Pediococcus acidilactici B-LC-20, LR: Lactobacillus rhamnosus 
Lyofast LRB, LP: Lactobacillus plantarum Lyofast LPAL, LPP: Lb. plantarum Holdbac, LLN: Lactococcus lactis ssp. lactis BS-10.  
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FIGURE 1 Listeria monocytogenes counts (Log CFU/mL ± SD) in raw milk following refrigerated storage overnight, co-culture with 
PCs the following morning, and following a cheesemaking time and temperature profile. 
 
Dotted line indicates LM inoculation level prior to overnight refrigeration.  
a-c Columns within a time point with different letters differ at  P < 0.05 .  
LM: L. monocytogenes cocktail, LR: Lactobacillus rhamnosus Lyofast LRB, PA: Pediococcus acidilactici B-LC-20, LP: 
Lactobacillus plantarum Lyofast LPAL, LPP: Lb. plantarum Holdbac, LLN: Lactococcus lactis ssp. lactis BS-10.  
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CHAPTER V 
FATE OF LISTERIA MONOCYTOGENES AND SHIGA TOXIN-PRODUCING 
ESCHERICHIA COLI DURING MANUFACTURE AND AGING OF A SURFACE-
MOLD-RIPENED SOFT CHEESE MANUFACTURED WITH PROTECTIVE 
CULTURES AS ADJUNCTS.
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ABSTRACT 
Soft-ripened cheese supports survival and growth of pathogens Listeria monocytogenes 
(LM) and shiga-toxin producing Escherichia coli (STEC). The potential presence of these 
pathogens in unpasteurized milk elevates the risk of foodborne illness upon consumption of 
cheese manufactured with unpasteurized milk. Protective bacterial cultures (PCs), producing 
non-specific defenses such as bacteriocins, represent a potential biological control strategy 
compliant with the Standard of Identity of cheese. The purpose of this study was to evaluate two 
commercially available protective cultures for the control of LM or STEC in a surface-mold-
ripened soft cheese. Cheese was manufactured in the lab from raw milk intentionally 
contaminated with 6 and 7 strain cocktails of either LM or STEC, respectively, at a concentration 
of ~2 log CFU/mL prior to manufacture. Commercially available PCs previously identified as 
effective against each pathogen were added to contaminated milk at a concentration of ~6 log 
CFU/mL according to manufacturer instructions. After de-hooping and dry salting, cheeses were 
ripened in a controlled environmental chamber (12°C, 93% RH) for 14 days prior to storage at 
4°C up to day 63 and 7°C for another 8 weeks. Pathogens were enumerated throughout the 
cheesemaking process and bi-weekly throughout ripening and storage. Two independent batches 
of each control and treatment were used for analysis. STEC, but not LM, concentration increased 
over milk ripening. Both pathogens were concentrated in the cheese curd over the course of 
manufacture and pressing. Mean LM concentration in control and treatment cheeses decreased 
slightly by day 35, relative to starting inoculation, and increased gradually out to day 120. LM 
counts were associated with the extent of cheese ripening, which varied between trials. STEC 
was detectable in cheese out to day 120.  
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HIGHLIGHTS 
• Treatment with Protective Culture did not reduce LM counts in milk during ripening 
• LM grew in cheese treated with Nisin-producing protective culture 
• STEC populations decreased but remained enumerable for over 120 days of ripening   
 97 
 
 Recent analysis of historical outbreak data has shown that unpasteurized dairy products 
cause 840 times more illnesses and 45 times more hospitalizations than pasteurized products 
(11). The prevalence of pathogens Listeria monocytogenes (LM) and Shiga toxin-producing 
Escherichia coli (STEC) in cheese made from raw milk is higher than that of cheese made from 
pasteurized milk, elevating the risk of associated infection and illness upon consumption (32, 
38). LM and STEC infections are rank among the highest rates of death and hospitalization 
respectively of all food borne illnesses (50). In 2017 an outbreak of listeriosis resulting in eight 
hospitalizations and two deaths was linked to a washed rind raw milk cheese produced by a New 
York Creamery (6). Multiple international recalls since the beginning of 2019 (21, 22) further 
emphasizes continued public health risk associated with raw milk cheese. Without 
pasteurization, pathogens such as LM and STEC are not eliminated from raw milk prior to 
cheesemaking. Physicochemical characteristics such as the high moisture content and the 
increases in pH in surface ripened soft cheeses during ripening and storage allow for survival of 
pathogens, if present, compounding the risk of food borne illness. FDA regulations require that 
cheeses made using raw milk be aged for a minimum of 60 days at a temperature no less than 
1.6°C (9). Both STEC and LM have been documented to survive past the mandatory 60-day 
aging period in the United States in these and other cheeses (12). Globally, soft-ripened cheeses 
made from raw milk have caused numerous infections, hospitalizations (3, 30), deaths (20), and 
prompted international recalls (24), establishing an urgent need for validated control strategies 
for these pathogens in this specific cheese type. 
The use of metabolites produced in situ from protective cultures (PCs) of lactic acid 
bacteria is a promising naturally-derived antimicrobial strategy allowable by the standard of 
identity of cheese (21 CFR 133) (2, 18). Pervious work using PCs and their bacteriocins has 
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supported their potential for pathogen control in the production of cheese (4, 36, 55). Many of 
these studies were completed in pasteurized milk using laboratory strains of PCs or their 
bacteriocin preparations, both of which are not approved yet for use in food, nor available for 
widespread use. Select cultures with anti-microbial properties are commercially available to 
producers, each targeting one of many safety and quality issues in dairy products. Presently, 
protective cultures are used in cheese for control of Clostridia spores to prevent gas-blowing 
defects, and reduce yeast and mold contaminants. Documentation of anti-pathogenic activity of 
commercially available strains is minimal in the literature, despite multiple options presently for 
sale. The present work aims to evaluate two commercially available cultures for control of LM or 
STEC in a surface mold-ripened soft cheese made from raw milk. 
MATERIALS & METHODS 
Bacterial cultures and cocktail preparation. Previous work in our lab identified top-
performing commercial protective cultures against each LM (Chapter IV) and STEC that did not 
inhibit acidification activity of common cheesemaking starter cultures (Chapter III). Direct vat 
set cultures of Lactococcus lactis ssp. lactis Bio-Safe-10 (LLN) (Chr. Hansen Inc., Milwaukee, 
WI) and Hafnia alvei LALCULT Protect B16 (HA) (Lallemand Specialty Cultures, Rhinelander, 
WI)  were found effective against LM and STEC, respectively. Cultures were added directly to 
milk to achieve a target count of ~6 log CFU/mL. Cell counts for LLN confirmed by 
enumeration following serial dilution in 0.1% peptone (BD- Difco, Franklin Lakes, NJ), plating 
onto de Man Rogosa Sharpe (MRS) agar (BD) and incubation at 30°C for 48 h. HA counts were 
confirmed by enumeration on plate count agar supplemented with 1% skim milk powder (Price 
Chopper, Schenectady, NY), 5mg/L vancomycin (Fisher Scientific, Waltham, MA), and 5mg/L 
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crystal violet (Fisher Scientific) following incubation at 30°C for 48 h as described by Delbus et 
al. (2013) (16).  A six strain cocktail of LM was prepared with strains associated with dairy-
related outbreaks of listeriosis including: ATCC 51414 (raw milk); CWD 675-3 (raw milk); 
Scott A; 2012L-5323 (Ricotta Salata); 2014L-6025 (Hispanic-style cheese); and DJD 1 (washed-
rind cheese) (33). A seven-strain cocktail of Shiga toxin-producing Escherichia coli (STEC) was 
prepared to include non-O157:H7 E. coli strains representing the six major serogroups (O26:H11 
NRRL B-59821, O103:H2 NRRL B-59827, O45:H2 NRRL B-59823, O121:H19 03-2832 NRRL 
B-59834, O145:NM 03-4699 NRRL B-59836, and O111:NM 94-0961) and an acid tolerant 
strain of E. coli O157:H7 (ATCC 700599) isolated from salami. Frozen (-80°C) stock cultures of 
each pathogen were inoculated individually into 9 mL of tryptic soy broth with 0.6% yeast 
extract added (TSBYE) (BD) for STEC or brain heart infusion broth (BHI) (BD) for Listeria. 
Cultures were incubated at 37°C for 18 h for two subsequent transfers before use. For each 
pathogen, equal proportions of cells from each culture were combined as a cocktail.  The 
resulting cocktail was pelleted through centrifugation (4,000  g for 15 min at 4°C) (Thermo 
Scientific Sorvall Legend X1R, ThermoFisher Scientific, Waltham, MA), and re-suspended in an 
equal volume of 0.1% peptone. 
Milk Collection. Raw milk was aseptically collected from the bulk tank at the Kellogg 
Dairy center at the University of Connecticut in sterilized carboys ( Thermo Scientific 22500050 
20L Nalgene,  Fisher Scientific) using a sanitized siphon (Beckson Marine Siphon-Mate Transfer 
Pump, Grainger Industries, Miami, FL) and sterile tubing (Tygon B-44-4X, Fisher Scientific). 
Milk was transported to the lab within one hour and stored at 4°C prior to use the following 
morning. Each batch of milk was screened for presence of L. monocytogenes and STEC 
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according to the methods outlined in the FDA Bacterial Analytical Manual (19, 26). Briefly, 25 
mL samples were enriched in 225 mL Buffered Listeria Enrichment Broth at 30°C for 4 h, 
followed by 44 hours of selective enrichment at 30°C. Aliquots of 100μL were streaked onto 
CHROMagar Listeria (DRG International Springfield, NJ), incubated for 48h at 37°C, and 
examined for the presence of typical colonies (teal in color surrounded by a halo).  For STEC, 25 
mL samples of milk were enriched in 225 mL of modified buffered peptone water with pyruvate 
(mBPWp) (Fisher Scientific) at 37°C for 5 h followed by selective enrichment overnight at 42°C. 
Aliquots of 100uL were then streaked onto CHROMagar STEC (DRG International), incubated 
24h at 37°C, and examined for typical colonies (mauve).  
Cheese Manufacture. Small format surface-mold-ripened soft cheeses were 
manufactured following a traditional Camembert cheese technology in a laboratory-scale cheese 
vat (Labtronix Inc., Philomath, OR). On the day prior to cheese manufacture, a 50 mL portion of 
raw milk was inoculated with the appropriate pathogen cocktail to achieve 2 log CFU/mL in the 
6 gallon batch the next day and stored at 4°C overnight to simulate contaminated milk being held 
prior to cheesemaking. On the day of manufacture, the vat, hoops and ripening and draining mats 
were cleaned and then sanitized using 200 ppm sodium hypochlorite (Low Temp Sanitizer, 
Alpha Chemical Services, Stoughton, MA). Twenty-three liters of raw milk was added to the vat 
prior to the addition of the 50 mL portion of raw milk inoculated with the pathogen. Treatments 
included LM alone (control), LM with LLN, STEC alone (control), and STEC with HA. Calcium 
chloride (New England Cheesemaking, Deerfield, MA) was added at 10 mL/100 L and the milk 
was warmed to 34°C. The starter and ripening cultures were added as follows: MM100 (4.5 
DCU/100 L), TA54 (2 DCU/100 L), KL71, GEO17, SAM3 (each 0.10 DCU/100 L) (Danisco-
Dupont, New Century, KS). Protective cultures were added to milk at a concentration of 6 log 
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CFU/mL. HA culture was added to STEC contaminated milk according the manufacturer’s 
instructions prior to the addition of starters. The addition of LLN was delayed 15 minutes after 
the addition of the starter cultures based on the manufacturer’s recommendation and previous 
results in our lab to minimize potential inhibition of starter cultures. Milk was mixed at 
approximately 45 rpm using a pitched-blade overhead paddle assembly. Temperature was 
maintained at 34°C for ~4 hours until a target pH of 6.3 was attained. Milk was stirred for 45 
seconds following the addition of coagulant (DCI Star Coagulant Double strength microbial 
coagulant, Dairy Connection  Inc., Madison, WI) at 4.4 mL/100 L diluted 1:80 in deionized 
water. Cutting time was determined by multiplying the time to flocculation by 6. Once the 
desired firmness was reached, heat to the vat was removed and the coagulum was cut into ~1 
inch cubes. Curds were stirred gently for five minutes followed by five minutes of rest. 
Approximately 15% of the whey (3.5 L) was drained off and curds were ladled into hoops 
(M608MTS185, 80mm diameter, Fromagex, Quebec, Canada) on sanitized racks with draining 
mats (M603STO010, Fromagex) over four additions. Cheeses were transferred to a 25°C 
incubator and flipped after 2.5 hours of draining. The temperature of the incubator was then 
reduced to ambient (20-22°C) and the cheeses were flipped hourly for 2-3 hours, and then 
allowed to drain overnight.  
Salting, Drying, Ripening and Holding. The following morning, cheeses were de-
hooped and dry salted (Diamond Crystal Kosher salt, Cargill, Minneapolis, MN) at 1.95% of the 
cheese weight. Cheeses were then placed on stainless-steel aging racks (Fromagex) and dried in 
a climate controlled environmental chamber (Caron Products Inc, Marietta, OH) at 12°C and 
85% relative humidity for 48 h. The humidity was then increased to 93% and cheeses were aged 
for 10-14 days until mold growth sufficiently covered the cheese. Cheeses were turned daily 
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throughout the drying and aging phases. At the end of aging cheeses were wrapped (White Mold 
Paper, Fromagex), stored at 4°C for 63 days, and then stored at 7°C through 120 days. 
Temperature (Oakton Temp300 data logging thermocouple, OAKTON Instruments, Vernon 
Hills, IL, USA) and pH (Accumet AB150, Fisher Scientific) were measured throughout 
manufacture.  
Bacterial Enumeration. Duplicate 25mL samples of raw milk were removed at the time 
of milk collection to assess milk microbial quality. Milk standard plate counts (SPC) were 
determined using the Petrifilm Aerobic Count Plate (3M, St.Paul, MN) method (45). Counts 
were rounded to two significant figures at time of conversion to SPC. Total coliform counts were 
determined using 3M Petrifilm E.coli/Coliform count plates following the manufacturer’s 
instructions. Plates were incubated at 32 ± 1°C for 24 ± 1 h. Mesophilic lactic acid bacteria were 
enumerated on MRS under the same incubation conditions described earlier for PC enumeration. 
During cheese manufacture, duplicate 10 mL samples of un-inoculated milk, inoculated milk, 
milk after ripening and whey after stirring were removed for pathogen enumeration. Samples 
were serially diluted in 0.1% peptone before plating onto MRS, CHROMagar Listeria or 
CHROMagar STEC and incubated as previously described. Gram negative agar described by 
Callon et al. (2016) was used to approximate the total Gram negative counts for cheeses 
inoculated with HA (5). Typical cream colored colonies were enumerated after incubation at 30 
± 1°C for 48 ± 1 h. 
Duplicate samples of curd (25g) were removed at the time of cutting and first flipping. 
Duplicate cheese samples (25g) were collected prior to salting, on days 1 and 7 of aging, and 
then bi-weekly through 120 days.  At each sampling time point, a single cheese was randomly 
selected from each batch, cut in half using a sterile knife, transferred to sterile bags (24oz Whirl-
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pak, Fisher Scientific) and macerated by hand until a homogenous paste was obtained. 
Subsamples of 25g were homogenized (Smasher stomacher, Biomerieux, Marcy-l'Étoile, France) 
for 1 min at 560 strokes/min) in 100mL of BLEB or mBPWp for LM and STEC, respectively. 
Following serial dilutions in 0.1% peptone, homogenates were plated onto their respective 
chromogenic agar. When applicable, 1 mL of homogenate was plated over 4 agar plates (250μL 
per plate) to achieve a detection limit of  5 CFU/g. When colony counts fell below the limit of 
detection, an additional 125mL of the enrichment broth was added and standard enrichment 
procedures were followed as described earlier.  
Physiochemical Analysis. Physiochemical analyses conducted on representative samples 
from each independent batch of cheese, in duplicate, at the day 7 time point, included dry matter 
(DM) (forced draft oven method; Hooi et al., 2004), fat (Babcock method; Hooi et al., 2004), and 
salt (Quanttab Chloride, Hach, Loveland, CO). Duplicate pH readings were taken at the rind, just 
below the surface of the cheese, and at the center of each cheese before homogenization. Salt in 
moisture (SM), moisture in the non- fat substance (MNFS), and fat in dry matter (FDM) were 
determined using the following formulae: % SM = [% salt/ (100 − % DM)] × 100; % MNFS = 
[100 − % DM/ (100 − % fat)] × 100; and % FDM = (% fat/% DM) × 100. Compositional targets 
were dry matter ~50%, fat ~22-23%, salt ~1.7%. 
Statistical Analysis. Eight batches of cheese were independently manufactured on 
separate days including two batches for each pathogen with and without the respective PC. For 
each pathogen, counts were pooled and means were analyzed using the GLM procedure of SAS 
9.4 with the interaction of time and treatment. Least square means of the interaction were 
calculated and compared using Tukey post-hoc testing.  In the absence of an interaction, Least 
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Square Difference of main effect means was used to assess differences. Significant differences 
were considered at P < 0.05. 
RESULTS AND DISCUSSION 
Raw milk microbial quality. There is no federal limit established for coliforms in raw 
milk used for cheesemaking. Since coliforms can enter the milk from multiple environmental 
sources, high coliform counts are associated with loss of hygienic control during milk collection, 
milking of mastitic cows or improper temperature control during storage. However, a correlation 
between pathogen presence and coliform counts has not been established (14, 28, 53). 
Recommended counts range from <10 CFU/mL to <100 CFU/mL (1). Coliform count in the 
present study ranged from 18 to 56 CFU/mL with a mean of 38 CFU/mL. The mean SPC for raw 
milk (420 CFU/mL) was low in the context of current limits for Grade A milk (<100,000 
CFU/mL) and recommendations for cheese (<10,000 CFU/mL) (1, 51). All batches of raw milk 
used for cheesemaking were negative for the presence of LM and STEC. 
Cheese Composition. US federal regulation requires that soft-ripened cheese made from 
raw milk must be held for a minimum of 60 days at a temperature no less than 1.67°C (35°F) (9). 
The federal Standard of Identity for soft-ripened cheese also specifies a minimum FDM of 50% 
(8). The FDM for all cheeses in the present study were above this limit except those 
manufactured with LLN, which were lower (45.48 ± 3.31% FDM) (Table 1).  Dry matter, fat and 
salt content were all within acceptable range of targets and means of all compositional metrics of 
both LLN and HA treated cheeses were not significantly different from respective controls.  
Cheeses were manufactured with lower target moisture content at dehooping, to slow the rate of 
ripening to achieve a desirable texture following the mandatory 60 day aging. Desired extent of 
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ripening for salable quality of all cheeses was subjectively reached by day 70. Lower measured 
fat content for cheeses treated with LLN, contributing to a calculated lower FDM, was likely a 
result of incomplete digestion of sample by sulfuric acid during analysis. Fat content is only 
determined by the milk used and cannot be modified with the addition of protective culture. 
Inaccurate fat analysis is a more likely explanation of differences observed.  
Changes in pH of Cheese. Target pH of 4.65 in finished cheese at time of dehooping 
was met. Change in pH over time at the center of individual cheeses treated with LM was not 
impacted by the addition of LLN. pH of the center of the cheeses treated with HA only differed 
from control only on day 7 (P = 0.049) and day 63 (P = 0.011). The pH of the rind of all cheeses 
increased rapidly from 4.6 to >6 within the 21 days of aging (Figure 1) as a result of proteolytic 
activity of surface molds, consistent with observations of other researchers (49). pH did not 
differ at any time point between treatment and control for either pathogen.  
Population of lactic acid bacteria and Hafnia alvei during cheese manufacture and 
ripening. Mesophilic LAB counts exceeded 8 log CFU/mL in milk after addition of starter 
cultures and remained near that level (>7 log CFU/g) in all cheeses through the duration of 
sampling. Total Gram negative counts, a proxy for HA concentration, increased by ~ 1 log from 
inoculation initial inoculation levels throughout pressing then decreased over the course of 
ripening and aging from 7.92 log CFU/g on day 1 to 6.46 log CFU/g on day 120 (Data not 
shown). Other studies using this culture in a semi-hard model cheese observed a similar increase 
in Hafnia count early in manufacture followed by gradual decrease over 40 days of cheese 
ripening (16). Plausible mechanisms of antimicrobial activity of HA (e.g. pH or bacteriocin 
production, competitive exclusion) are all dependent on high prevalence of the organism. 
Reduction in counts over time could limit extent of control.  
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Survival of STEC during cheese manufacture. Overall, STEC counts increased in the 
milk and curd over the course of manufacture (Table 2). Mean STEC counts during manufacture 
between cheeses made with and without PCs did not differ. Increase in STEC counts in curd 
after cutting and further increase in STEC counts during draining and flipping were consistent 
with previous reports of STEC growth and capture in the curd (40, 43). STEC (< 3 log CFU/mL) 
was also detected in drained whey, indicating an incomplete capture in the curd. This value is 
greater than that reported in studies of cheeses of other types (13, 23, 46), however differences in 
factors that drive curd strength and contraction (curd cut size, stirring, cooking time and 
temperature) may contribute to equilibrium of the pathogen in the whey and cheese resulting in 
higher values observed here. This is a concern since previous work has shown acid tolerance of 
STEC allows for survival and growth in cheddar cheese whey (37). This highlights the potential 
for cross-contamination of the cheesemaking environment and the farm environment if untreated 
whey is applied as an agricultural amendment. There is also the potential for animal infections if 
used as animal feed supplement, amplifying the potential for foodborne illness of other non-dairy 
food products.   
Behavior of STEC during drying and aging. Mean STEC count in both treated and 
untreated cheeses averaged 3.8 log CFU/g on the first day of aging, and decreased to 1.99 log 
CFU/g and 2.3 log CFU/g in control and treated cheeses, respectively, by day 120 (Figure 2B). 
STEC counts in PC treated cheeses was higher than control later in aging on days 63 (P = 0.046), 
77 (P = 0.03), 91 (P = 0.001), 105 (P = 0.004) and 120 (P = 0.043). However, counts only 
differed by <0.5 log CFU/g, which may not be biologically significant. Average weight of 
cheeses manufactured with HA did not differ from control, however gas production by HA 
produced small eyes in these cheese paste that reduced in size as cheeses ripened. 
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Low pH during cheese manufacture may have a greater impact on STEC behavior than 
HA activity alone. As mentioned previously, pH of soft-ripened cheeses decreases rapidly over 
the course of manufacture then gradually increases over ripening and storage. Miszczycha et al. 
(2013) demonstrated that when STEC growth was observed during the first step of manufacture, 
as seen here, STEC concentration in a lactic cheese decreased over 60 days of ripening, in part 
due to low pH and storage temperature (41). Multiple authors document similar patterns of 
STEC survival: persistence, albeit with reduction in concentration, in cheeses with pH as low as 
4.3 (43, 54). Among these, Montet et al. (2009) observed reduction, but not complete 
elimination, of both acid resistant and non-acid resistant strains of STEC in camembert cheese 
after 20 days of ripening as the pH rose from 4.66 at the end of molding to 5.11 on day 20 (43). 
STEC behavior and pH profile is similar to that seen of this present study, although acid-
resistance status of strains used here ismixed. Previous work using HA in an uncooked pressed 
model cheese made from raw milk reported a ~1 log CFU/g reduction in E.coli O26:H11 
compared to control one day after manufacture and maintained this difference out to day 28 of 
observation (16). The authors hypothesized that acetic acid production by HA may synergize 
with acid produced by milk consortium contributing to STEC reduction. The pH of the curd over 
this time frame did not drop below 5.33. However, STEC concentration was not reduced upon 
treatment with HA at the reduced pH of the cheese here. Key differences in composition between 
the pressed cheese and soft-ripened cheese might explain some differences, however, moisture or 
other metrics were not presented for comparison.   Optimal pH range for this culture is unknown 
but a low tolerance for high-acid environments might explain gradual decrease in total Gram 
negative count from initial inoculation observed in treated cheeses, which may contribute to the 
lack of inhibition observed. 
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Recent evidence has shown that survival of O157:H7 and non-O157:H7 strains, when 
adapted to acidic environments, is dependent on other food conditions such as water activity and 
food matrix (48). However, under select conditions, survival of O157:H7 and non-O157:H7 
serogroups were not significantly different regardless of acid adaption (48). Other researchers 
have confirmed differences in growth behavior of E. coli strains in raw milk cheeses, 
demonstrating that select non- O157:H7 serotypes may be better competitors than O157:H7. 
However this is dependent on cheese type (41, 42). As both O157:H7 and non-O157:H7 strains 
have been linked to outbreaks and recalls in raw milk cheese and commercial PC cultures have 
not been validated against these strains in this cheese type, a cocktail with representatives of each 
type was used to approximate the antimicrobial activity towards STEC in general. Therefore, 
survival of only a single or a few serotypes is possible. The selective and differential agar media 
used in the present study did not allow for differentiation of colonies based on serotype.  
It is important to note here, as in other studies, immediate regrowth of STEC is not 
observed in either treatment or control as pH increases over ripening. Additional compositional 
hurdles in the cheese or delayed recovery from acid adaption, if any, are plausible explanations. 
Hsin-Yi and Chou (2001) proposed that the benefit of E.coli O157:H7 acid-adaption in 
fermented milk products might be outweighed by an increase in susceptibility to antimicrobials 
of LAB and protective cultures, if present (27). Here, the rate of STEC reduction was not 
enhanced by PC presence. In fact, the addition of PC seemed to enhance STEC survival at later 
time points. Others have observed enhanced STEC survival in the presence of additional 
consortia when in culture media (17). Until the mode of action of HA is more precisely known, it 
does not appear that it enhances control of STEC in this cheese type. Further, the gas production 
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defect typical of Enterobacteriaceae as a result of HA addition means cheese visual appeal at 
time of sale may be reduced without a benefit to safety. 
Survival of L. monocytogenes during cheese manufacture. Mean LM counts in milk 
and curd samples of treated cheese were not significantly different from control throughout 
manufacture. A slight decrease in LM concentration was observed at the end of the 4 h ripening 
period (Table 2) followed by an increase at time of cutting, which is consistent with limited 
growth during ripening followed by concentration and entrapment in the curd described by 
others (35, 36). Limited duration at optimal growth temperature and high concentration of 
competing organisms can limit LM growth. LM was detected in whey at levels similar to that of 
other types of cheese (35), indicating an incomplete capture in the curd.  
Behavior of L. monocytogenes in cheese during drying and aging. Mean LM counts in 
cheeses treated with LLN were not significantly different from control at any time point (Figure 
2A). Variation in LM counts between replicates at later time points in both treatment and control 
cheeses is a major fault of this data set. Subjective visual observations at time of sample 
collection noted delayed ripening of one batch of LLN treated cheeses. pH values at the rind of 
these cheeses rose as anticipated,  but the total volume of the cheese at the pH amenable to LM 
growth was estimated to be less than that of other cheeses over storage. Efficiently distributing 
curds during hooping limited premature moisture loss and development of a rubbery curd 
texture.  However, uneven distribution of denser curds among forms may have resulted in 
cheeses of slightly different curd composition within a batch. Cheeses with a denser, lower 
moisture curd, may have inhibited diffusion and activity of proteolytic enzymes over the duration 
of storage of select cheeses.  
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Previous work suggested that the LLN culture would not impact acidification of 
mesophilic starter culture. However, there was the potential for inhibition of thermophilic culture 
TA54 (Chapter III). One batch of cheese produced with LLN took 75 minutes longer to reach the 
target pH for cutting compared to the average ripening time of the comparative LM control. 
Apart from this delay, pH values through the remainder of manufacture did not differ from 
anticipated values. There was also no indication that this delay affected LM counts and did not 
impact final cheese pH as differences in core and rind pH of final cheeses were not observed. 
Thermophilic cultures are used to complement the activity of mesophilic cultures by extending 
acid development late in the cheese make process. The delay in acidification early in the process 
during milk ripening suggests a potential inhibition of the mesophilic culture.  
Microbiological community activity and mold growth at the surface of the cheese result 
in key physiochemical changes over the course of ripening, allowing for Listeria growth and 
survival. After dry salting, colonization of the rind with ripening bacteria, yeast and mold, 
quickly metabolizes available lactose resulting in the diffusion of lactate and lactose from the 
center of the cheese. Activity of proteases produced by Penicillium candidum metabolizes 
proteins into component amines generating ammonia and raising the pH locally at the rind (34). 
Essentially, ripening activity and resulting changes in pH modulates both the ripeness of the 
cheese and environment available for LM growth. Concentration of LM increases in areas of 
cheese with a pH above 5.5 and high moisture content, as these conditions supports LM growth 
(49). Ryser and Marth (1987) reported strain-specific differences in survival of LM in cheese at 
pH levels >5.5 (49). As mentioned previously, cheeses in which LM did not grow did not ripen 
in the same manner as the others. This illustrates the key role of pH (as a consequence of 
protease diffusion and ripening activity) in controlling LM growth in this cheese environment. 
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The efficacy of protective cultures as adjuncts for controlling pathogens in surface-mold-
ripened soft cheeses varies.  Protective cultures used a primary starter cultures tend to be more 
effective. Maisnier-Patain et al (1992) observed a 1.5 log decrease in LM counts after the first 
day of production with a Lc. lactis subsp lactis CNRZ 150 as a starter. Limited regrowth was 
observed in the treated cheese after 2 weeks of aging compared control, indicating that nisin 
production by this culture was essential for LM control (22) Bacteriocin production is suggested 
to be induced by the presence of other bacteria (10), however absence of competition from starter 
cultures or background microflora did not prevent nisin production in the aforementioned study. 
Suzler et al. (1991) observed an anti-listerial effect when  Lactococcus lactis 1881 was used as a 
starter alone in the production of camembert cheese, but not when added alongside another 
starter culture (52). Favorable levels of gene expression of nisA in milk and curd during Graciera 
cheese manufacture were measured in a separate study (44). However nisA transcript levels 
decreased post-fermentation, potentially due to prevalence of other cultures, transcript 
degradation or inactivation, or depletion of nutrients required for transcription, illustrating the 
potential impact of other cultures on potential for antimicrobial activity on the molecular level 
(44). Previous work in our lab demonstrated that LLN reduced LM counts in raw milk as early as 
four hours into incubation at 35°C. While it attempted to emulate cheesemaking, this experiment 
did not account for high concentration of starter culture or background microflora as variables 
potentially impacting PC activity and nisin production.  It is also possible that nisin, if produced 
in cheese, was diluted or enzymatically degraded under cheesemaking conditions. Absence of 
anti-listerial activity and lack of replication of our work from raw milk, could be attributed to a 
combination of one or more of the many factors influence nisin production, persistence, and 
ultimate degradation in cheese.  
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 Nisin production by Lc. lactis occurs throughout exponential growth and ceases when 
the growth rate decreases (31). Production is influenced heavily by environmental factors such as 
pH and available carbon source, milk being a suitable medium for consistent Nisin production 
(15, 47). Previous work both in our lab has shown that the anti-listerial activity of LLN was 
retained in the presence of proteolytic coagulants used for cheese making (data not shown). 
Other labs have demonstrated mixed susceptibility of nisin with other common food proteases 
(39), and susceptibility to select enzymes of the gastrointestinal tract (25, 29). Proteolysis and 
associated ripening of surface-mold-ripened soft cheese is the result of enzymes predominantly 
produced by P. candidum, with small contribution by Geotrichum species and LAB. Evidence of 
nisin susceptibility to the aspartyl protease, metalloprotease, and exopeptidase produced by P. 
camemberti (7), and auxiliary proteinases produced by LAB and other has not been exclusively 
tested. Others have observed nisin titer decreased in ripened cheeses after mold development, 
suggesting that this bacteriocin might be labile to enzymatic activity of the molds (36). In the 
absence of commercialized nisin-producing starter culture blends, more cheesemaking trials are 
needed to identify process parameters and application methods necessary to balance 
commercially available Nisin-producing protective cultures and existing starter cultures such that 
neither inhibits the activity of the other. 
In summary, aging alone was not sufficient to eliminate L. monocytogenes or STEC in a 
surface-mold-ripened soft cheese made with raw milk. Both pathogens were detectable in 
cheeses 120 days after manufacture. As cheeses ripened as a result of proteolytic activity from 
surface molds LM increased in concentration, while STEC decreased. The addition of protective 
bacterial cultures with demonstrated efficacy in raw milk did not provide additional control of 
these pathogens under the conditions tested. Additional research studies are needed to optimize 
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use of commercially available protective cultures in high-risk cheese types prior to validating 
their use for the control of pathogens. 
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TABLES AND FIGURES 
TABLE 1. Composition (% +/- SD) of surface-mold-ripened soft cheese on day 7 of ripening when manufactured with and without 
protective cultures  
  
DM  Moisture Fat Salt FDM 
LM 53.89 ± 4.54 46.11 ± 4.54 29.63 ± 4.07 1.87 ± 0.22 54.85 ± 2.92 
LM + LLN 52.91 ± 3.53 47.09 ± 3.53 24.13 ± 3.36 1.86 ± 0.15 45.48 ± 3.31 
STEC 51.32 ± 3.31 48.68 ± 3.31 28.88 ± 4.07 1.96 ± 0.29 56.12 ± 4.30 
STEC + HA 48.96 ± 0.08 51.04 ± 0.08 27.25 ± 1.06 1.84 ± 0.22 55.66 ± 2.26 
 
DM: dry matter; FDM: fat in dry matter; LM: Listeria monocytogenes; STEC: shiga toxin-producing Escherichia coli; LLN: 
Lc. lactis ssp lactis; HA: Hafnia alvei.  
Treatment and control means were not significantly different from one another (P< 0.05)  for any composition measurement 
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FIGURE 1. Change in cheese pH over time when manufactured from raw milk contaminated 
with Listeria monocytogenes (LM) (A) or shiga toxin-producing Escherichia coli (STEC) (B) 
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Squares represent the pH at the rind (□ Pathogen, ■PC) and triangles represent pH in the cheese 
center (Δ Pathogen, ▲PC). Error bars show standard deviation, * indicates significant difference 
(P< 0.05) between treatment and control. 
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TABLE 2. Mean counts (log CFU/ml or g ± SEM) of Listeria monocytogenes (LM) and shiga 
toxin-producing Escherichia coli (STEC) in milk and curd during the manufacture of cheese with 
and without protective cultures. 
LLN: Lc. Lactis ssp lactis, HA: Hafnia alvei 
Counts in treatments were not significantly different (P< 0.05) from controls at all sampling 
points.  
*- Value from single trial, SEM and variability were not calculated 
  
  
Inoculated 
milk  
Ripened 
milk  
Whey   
Curd at 
cutting 
Cheese at 
first flip  
Cheese 
before 
salting 
LM  2.43 ± 0.24 2.00 ± 0.34 0.96 ± 0.58 1.96 ± 0.40 2.23 ± 0.61 2.79 ± 0.47 
LM +LLN 2.25 ± 0.31 2.22 ± 0.15 0.82 ± 0.12 2.02 ± 0.25 2.26 ± 0.10 2.90 ± 0.15 
STEC  1.99 ± 0.21 3.09 ± 0.02 2.50 ± 0.46 3.76 ± 0.08 4.08 ± 0.004 3.84 ± 0.34 
STEC +HA 2.09 ± 0.24 2.88 ± 0.11 1.97 ± 0.23 3.14 ± 0.26 3.34 * 3.57 ± 0.13 
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FIGURE 2A. Change in counts (log CFU/g) of Listeria monocytogenes (LM) in cheese 
manufactured with and without protective cultures during aging. Emboldened lines trace the 
mean of two independent cheeses made with pathogen only (dotted) and pathogen and treatment 
(solid). Pathogen counts from individual replicates of control (○) and PC treated (♦) cheeses are 
also displayed.  LLN: Lc. Lactis ssp lactis, nisin producer. 
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FIGURE 2B. Change in counts (log CFU/g ± SD) of shiga toxin-producing Escherichia coli 
(STEC) in cheese manufactured with and without protective cultures during aging. Lines trace 
the mean of two independent cheeses made with pathogen only (dotted) and pathogen and 
treatment (solid). HA: Hafnia alvei.  
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* means differed significantly (P <0.05). 
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SUPPLEMENT 
FIGURE S1. Gas defect in cheese treated with HA protective culture at day 1 (A), 63 (B) and 
105 (C) of aging. 
A 
B 
C 
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FIGURE S2. Ripening observations of LM and LLN treated cheeses. Degree of ripening in trial 
01 was not the same extent as LM control at the same timepoint. 
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CHAPTER VI 
SUMMARY 
 128 
 
Listeria monocytogenes and shiga toxin-producing Escherichia coli pose significant risk 
to public health. Documented survival in raw milk cheese, in part due to favorable 
physiochemical changes over the course of cheese ripening, underscores the urgency to identify 
an easy-to-implement control strategy compliant with the standard of identity of cheese. This 
research examined the potential use of commercially available protective cultures for the control 
of Listeria monocytogenes and shiga toxin-producing Escherichia coli in soft surface mold 
ripened raw milk cheese. The first objective of this study was to assess compatibility of 
protective cultures with common cheesemaking starter cultures, ripening bacteria, yeasts and 
molds. Nine PCs did not inhibit growth or acid production of the starter cultures tested. PC 
inhibition of ripening bacteria and fungi was strain specific. This work created reference matrices 
for future use by cheesemakers to anticipate potential incompatibility with intended cheese 
cultures prior to selecting and using a PC.  
The second objective of this study was to determine the antimicrobial activity of 
commercial protective cultures against L. monocytogenes when in raw milk. Five members of the 
original panel were tested. Two cultures (LR, PA) did not impact growth of L. monocytogenes, 
two cultures (LP, LPP) exerted a bacteriostatic effect and one culture (LLN) limited L. 
monocytogenes to <1 log CFU/ml throughout testing. This culture was selected for use in 
cheesemaking, despite previous observations of potential starter culture antagonism.  
The third objective of this study was to determine the effect of commercial protective 
cultures on L. monocytogenes or STEC during the manufacture and storage of soft-ripened 
cheese made with raw milk. Treatment with nisin-producing LLN protective culture did not 
reduce L. monocytogenes counts in milk over ripening. Further, L. monocytogenes grew in 
cheese treated with this protective culture; however variation between trials inhibits any 
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definitive conclusion about the impact of the PC on L. monocytogenes growth in this cheese. 
STEC survived in soft-ripened cheese for over 120 days of ripening. Addition of HA protective 
culture did not impact STEC survival during manufacture or early in ripening, however may 
slightly enhanced survival late in ripening, as such this culture might not be the appropriate for 
this cheese type. Suspected impact of starter culture on protective culture performance prompts 
the need for additional testing to optimize application. 
 These results together identify the select compatibility of protective cultures with 
cheesemaking cultures and the potential for select PCs to control L. monocytogenes in raw milk.  
However further work is needed to optimize application and use parameters for control of 
pathogens in soft surface mold-ripened cheese.  
 
 
 
